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Minimal inhibitory concentrations (MICs) of 27 
antimicrobial agents were determined for 523 non-
duplicate Escherichia coli isolates, with 222 from 
blood, 101 from bile and 201 (ampicillin-resistant) 
from urine specimens in the Prince of Wales Hospital, 
Hong Kong. Almost all the isolates were sensitive to 
the latest beta-lactam antibiotics, aztreonam and .... . “ • • . . . _ 
imipenem and to third generation cephalosporins 
including ceftazidime, cefotaxime, and ceftriaxone. 
Forty-five percent and 38% from blood and bile specimens 
respectively were resistant to ampicillin and 
amoxycillin. Of the 340 ampicillin-resistant strains 
selected, more than 3% were resistant to cefamandole 
and about 2% to cefoperazone and cefuroxime, and none 
of them was susceptible to the first generation 
cephalosporins or the ureidopenicillins tested. Nearly 
half of the ampicillin-resistant isolates (171/340) were 
resistant �t o ampicillin and the beta-lactamase 
inhibitor, sulbactam and about 40% (140/340) t o� 
combination of ainoxycillir| and another beta-lactamase 
inhibitor, clavulanic acid. 
Both acidimetric and nitrocef in assays 
revealed that beta-lactamase was produced by the 340 
ampicillin-resistant strains. The enzymes were 
identified by analytical isoelectric focusing (lEF): 303 
^ (89.1%) were TEM — 1, 11 (3.2%) PSE-1, and 10 (2.9%) 
I 1 
� 
OXA-1. Ten (2.9%) of the strain produced both TEM-1 and 
PSE-1. Chromosomal-mediated (CHR) enzymes were detected 
in five organisms and one unidentified enzyme was found 
having an pi value of 6.0. No TEM-2 was found. The 
distribution of beta-lactamase was further revealed 
genetically by DNA hybridization using TEM-1, TEM-2 and 
OXA-1 oligonucleotide probes. 
The ampicillin-resistant E• coli when tested 
against an extend range of ampicillin from 0.06 to 
16,384 mg/1, could be divided into two groups of high-
level resistance (MIC > 2048 mg/l) and low-level 
resistance (MIC < 1024 mg/l) (28%/72%). Organisms with 
high-level resistance to ampicillin and amoxycillin had 
reduced susceptibility to ampicillin/sulbactam and 
amoxycilin/clavulanate. Positive correlations were 
found between ampicillin MIC and ampicillin/sulbactam 
MIC (r= 0.86) , in addition, ampicillin MIC and beta-
lactamase activity (r= 0.75). All the ampicillin-
resistant isolates contained (often multiple) plasmids 
and the ampicillin-resistance was transferable to 
sensitive recipient by conjugation. � 
Ampicillin/sulbactam resistant isolates had 
ampicillin/sulbactam MIC range of 16/16 to 64/64 mg/l, 
despite having high ampicillin MICs. This was because 
the organisms were inhibited by the sulbactam component 
at concentration of 64 mg/l. 
Ampicillin-resistance was transferred to a 
< sensitive recipient from an ampicillin/sulbactam-
• • 11 
� 
resistant (U117) and ampicillin/sulbactam-sensitive 
(B117) strain randomly selected after reviewing their 
ampicillin MICs. The beta-lactamases from 
transconjugants TU117 (MIC of ampicillin = 4096 mg/1, 
ampicillin/sulbactam = 64 mg/1) and TB117 (MIC of 
ampicillin = 128 mg/1, ampicillin/sulbactam = 4 mg/1) 
were purified by gel filtration chromatography and 
preparative lEF to homogeneity, with 80-fold and 300-
fold purification respectively. The purity of the 
enzymes was investigated by biochemical methods, ；-single 
protein bands were obtained in lEF (pi 5.40) and by SDS-
Polyacrylamide gel electrophoresis (MW 22,000). These 
beta-lactamases also had identical substrate profiles. 
Comparative qualitative analysis of the beta-
lactamases produced by TU117 and TB117 showed that 
although differences in the specific activities (715 and 
166 umol of ampicillin/min/mg protein) were observed in 
crude preparations, the enzymes purified to homogeneity 
showed no significant difference in their respective 
specific activities (56,431 and 53,017 umol of 
ampicillin/min/mg protein). However, comparative� 
quantitative analysis on .the total activities of the 
enzymes showed that the. ampicillin/sulbactam-resistant 
transconjugant produced seven times more enzyme in crude 
preparations and nine times more in purified 
preparations than did the ampicillin/sulbactam-sensitive 
counterpart. These results confirmed that 
ampicillin/sulbactam and amoxycillin/clavulanate 
• • • 111 
� 
resistance in E. coil was due to hyperproduction of 
normal TEM-1 beta-lactamase. 
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Septicaemia caused by E • coli is common in 
Hong Kong with high percentage of ampicillin-resistant 
E. coli isolated (French & Ling, 1988; French et al •, 
1990)• So far there has not been extensive survey of B-
lactamases in Hong Kong and the complete lack of 
information of the distribution of these enzymes in this 
region deserves attention. This study will provide 
information on the distributions of 3-lactamases arid the 
sensitivity profiles of ampicillin-resistant E• coll 
isolated locally. With the epidemiological findings and 
biochemical investigation on the mechanism of resistance 
mediated by J3 - lactamase, we may provide useful 
information for effective antibiotic therapy. 
The objectives of this study are: 
1. to elucidate the molecular epidemiological aspects 
on the local isolates of ampicillin-resistant E • 
coli, with major emphasis on their antibiotic 
profiles, especially to 13-lactams, transfer o f � 
resistance, the production of plasmid-mediated 13-
\ 
lactamases. 
2. to elucidate the mechanism of ampicillin-resistance 
mediated by 5-lactainases in selected isolates, 
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LITERATURE REVIEW 
1. Structure of the bacterial cell envelope 
Bacteria are prokaryotic cells which possess a 
characteristic cell wall surrounding the cytoplasmic 
membrane. The main cell wall component is 
peptidoglycan, also known as mucopeptide, glycopeptide 
or murein. The central structure of mucopeptide is a 
chain of N-acetylglucosamine and N - a c e t y Imur am i 9. acid 
molecules connected alternately by a 13-1,4 linkages 
(Figure 1) . The N-acetylmuramic acid molecules each 
carry a short tri-, tetra- or penta-peptide side-chain 
containing D- and L-alanine, D-glutamic acid and either 
L一lysine or diaminopimelic acid. These are further 
cross—linked by peptide chains to form a network (Figure 
2) . The cell wall contains other components whose 
nature and amount vary with the species. Bacteria can 
be divided into two broad groups depending on the 
reaction of their cell walls during Gram,s staining. 
Cell walls of Gram-positive bacteria (Figure 3) are� 
generally simple and are usually composed of amorphous 
matrices of interwined peptidoglycan and secondary 
polymers of teichoic acids (polyglycerol phosphate or 
polyribitol phosphate)• In Gram-negative bacteria, the 
cell wall is more complex, comprising an outer membrane 
(OM) of lipopolysaccharide (LPS), protein and 
phospholipid, and an inner layer of peptidoglycan (PG) 
2 
(Figure 4) (Costerton & Cheng, 1975)• 
The cell wall maintains the osmotic integrity 
of the bacterium thus allowing it to survive and grow 
despite differences in osmotic pressure between inner 
cell and outer environment. If the cell wall is 
weakened or ruptured, osmotic pressure forces water 
into the protoplasm resulting in cell lysis and death 
(Duguid, 1978). 
. . • - , 
In Gram-negative organisms, the outer 
membrane is a specialized structure that lies outside 
the cytoplasmic membrane and peptidoglycan layer. It 
forms the interface between the cell and its external 
environment. The membrane constitutes a physical and 
functional barrier which controls the entry of external 
agents into the cell. It serves as a barrier to 
antibiotics, detergents, and other toxic chemicals but 
allows entry of nutrients from outside. It also has 
receptors for bacteriophages and bacteriocins and allows 
cell to cell contact during conjugation. The membrane 
is made up of a battery of proteins which form 
transmembrane channels of varying degrees of specificity 
(Inouye, 1980)• The major protein is called porin 
which forms general hydrophilic pores (Nikaido & Nakae, 
1979; Osborn & Wu, 1980). The outer membrane also 
retains molecules produced by the bacteria. A 
periplasmic space is formed between the inner membrane 
and the outer membrane. The enzymes located in this 
3 
.-i-'v 
area play a major role in limiting the penetration of 
antibiotics to the intracellular target (Costerton et 
al., 1974). 
The cytoplasmic membrane contains many kinds 
of enzymes, including respiratory enzymes and pigments 
(the cytochrome system), enzymes of the tricarboxylic 
acid cycle and polymerizing enzymes that assist in the 
production of the cell wall and extracellular structures 
(Duguid, 1978)• 
2• The fi-lactam antibiotics 
The first antibiotic, penicillin, was 
discovered by Fleming in 1929 and introduced into 
clinical practice by Chain and Florey in 1941. 
Penicillin is a natural product of Penicillium notatum. 
Cephalosporin, derived from the fungus Ce phalosporium 
acremonium, was first described by Florey in 1955. 
Penicillins and cephalosporins had dramatic 
antibacterial activity against Gram-positive organisms, 
both in-vitro and in-vivo. These two compounds were 
both found to possess a J3-lactam ring structure (Figures� 
5 and 6) . Since their discoveries, a series of 
\ 
penicillins and cephalosporins have been introduced, 
some being natural products of various fungi and others 
synthesized by chemical manipulation of earlier drugs 
(Hamilton-Miller and Brumfitt, 1979)• Recently other 
B-lactam-like antimicrobial agents with different ring 
systems have been discovered and introduced into 
4 
clinical use, including monobactams such as aztreonam 
(derived from Chromobacterium violaceum) , and 
carbapenems such as imipeneiii (derived from Streptomyces 
cattleya) (Kahan et al. , 1983). All these compounds 
have a similar B-lactam ring structure and will be 
called B-lactams in this thesis (Figure 7)• 
3• Mode of Action of fi-lactam antibiotics 
• . . ‘ - • ‘ . 
In 194 6 Duguid noted that penicillins produced 
morphological changes in bacterial cells and postulated 
that the site of action of penicillin was on the 
biosynthetic pathway of the cell wall. Park and Johnson 
(1949) found that when Staph, aureus was inhibited by 
penicillin, UDP-N-acetylmuramyl pentapeptide accumulated 
in the culture medium. Since this pentapeptide is the 
precursor of murein, its appearance indicated the site 
of action of penicillin at the molecular level (Park, 
1952a, b, c) • Subsequently, extensive studies by 
Strominger and his colleagues (1967) revealed that part 
of the penicillin molecule is a close analogue of the 
terminal D-alanyl-D-alanine of the N-acetylglucosaminyl-
N-acetylmuramyl pentapeptide, which is a murein monomer, 
and penicillin competitively inhibits the activity of 
the murein transpeptidase which catalyzes the cross-
linking reaction between peptides of adjacent 
polysaccharide chains. Thus 3-lactam antibiotics exert 
their antibacterial effect by inhibiting the final step 
5 
•I 
of the biosynthesis of the bacterial cell wall. 
4. Penicillin-binding proteins (PBPs) 
Strominger and his colleagues (1967) suspected 
the existence of more than one cross-linking enzyme in 
the bacterial cells. Based on the theory that enzyme 
inhibitors bind competitively to active sites, 
cytoplasmic membrane proteins from Bacillus subtilis 
were analyzed by affinity chromatography using 
penicillin as the carrier. Five types of proteins were 
found to bind covalently to penicillin, and were 
designated penicillin-binding proteins (PBPs) 
(Strominger et al., 1974) . Since Spratt (1975) 
invented fluororadioautography to analyse PBPs, the PBPs 
of E • coli have been extensively studied. There are 
seven different proteins designated la, lb, 2, 3, 4, 
5 and 6, in descending order of molecular weight. The 
most important among the PBPs is lb, which is the murein 
transpeptidase necessary for cell elongation just before 
division. Fraction la is the accessory enzyme of lb, 
and fractions 2 and 3 are the murein transpeptidases� 
involved in the determination of cell shape and septum 
formation. Fractions 4 , 5 and 6 cleave D-alanine from 
the end of the murein pentapeptide monomer In-vitro 
(Spratt, 1978). 
B-lactams kill bacteria by binding to one or 
more PBPs and thereby inhibiting peptidoglycan 
biosynthesis which results in stepwise morphological 
6 
changes of emerging spheroplast resulting from 
defective cell wall, eventually leading to the formation 
of spheroplast and cell lysis (Spratt & Pardee, 1975; 
Spratt, 1977) . Most of the penicillins and 
cephalosporins bind to PBPs lb and la and produce 
elongation in Gram-negative organisms (Neu, 1976) • The 
amidinopenicillin mecillinam possess strong affinity for 
PBP 2, causing E. coli cells to produce rounded 
• 
. . •‘ • . - • ‘ 
spheroplasts (Spratt & Pardee, 1975; Neu, 1976)• 
5• Mechanisms of resistance to B-lactam antibiotics 
Soon after the introduction of penicillin in 
the early 1940Gram-positive isolates with acquired 
penicillin resistance began to be seen. In addition, 
it was also noticed that most species of Gram-negative 
bacteria are intrinsically resistant to the action of 
penicillin. Since then, bacterial resistance to J3-
lactams has become an increasingly important problem in 
antibiotic therapy. Several mechanisms of penicillin-
resistance are recognized which can be grouped under two 
main headings, namely the non-enzyme-mediated and 
enzyme-mediated mechanisms} 
5•1 Non-enzymatic resistance 
Non-enzymatic resistance results from the 
intrinsic ability of the bacterial cell to interfere 
with the mode of action of the antibiotic. Such 
7 
•I 
resistance was first recognized clinically when it 
became clear that Gram-negative bacteria were often 
resistant to B-lactams without the production of drug-
destroying enzymes (Garrod, 1981). There are three 
main mechanisms of non-enzymatic resistance: (1) 
alteration in cell permeability, (2) alteration in 
target proteins and (3) tolerance and persistence. 
5.1.1 Alteration in cell permeability 
- • . • . 
When the bacterial cell envelope has a reduced 
permeability to B-lactams, the antibiotic is prevented 
from entering the cell and interacting with its target 
sites. This mechanism of resistance occurs primarily in 
Gram-negative bacteria which have a complex outer 
membrane. It is now known that small hydrophilic drugs 
enter the bacteria through pores in the outer membrane 
that are formed by protein called porins (Nikaido & 
Nakae, 1979) • It was also demonstrated in mutant E. 
coli and Salmonella typhimurium that the rate of 
penetration of various B-lactams, though highly 
dependent upon hydrophobicity and molecular size, is 
\ 
reduced if the number of porins is markedly reduced 
(Nikaido & Nakae, 19 7 9V Nikaido, 1981). This 
alteration in permeability has been shown to be a 
particularly important drug resistance mechanism in 
Pseudomonas aeruginosa (Brown, 1975)• Enormous volume 
of literature on bacterial cell permeability changes to 
antibiotic penetrate and resistance has been reported in 
8 
the recent decade and undoubtedly the cell wall barrier 
effect on antibiotic penetration is established (Nikaido 
& Vaara, 1985; Hancock, 1987; Yamano et al•, 1990). 
5.1.2 Alteration of the target site 
B-lactams must bind to the target PBPs of the 
cytoplasmic membrane in order to inhibit cell wall 
synthesis. The production of PBPs with reduced binding 
affinity results in reduced antibiotic effect and hence 
increased antibiotic resistance. Such altered PBPs have 
been found in methicillin—resistant strains of Staph. 
aureus (Brown & Reynolds, 1980), and some penicillin or 
ampicillin-resistant strains of Neisseria gonorrhoeae 
(Dougherty, Roller & Toinasz, 1980), Streptococcus 
pneumoniae and Enterococcus faecalis (Williamson et 
al., 1983; Herman & Gerding, 1991). Such resistance 
is usually chromosomally-mediated. 
5.1.3 Tolerance and persistence 
The term antibiotic tolerance was originally 
used to describe the effect of penicillin on 
artificially-induced mutants of Strep, pneumoniae � 
defective in autolytic enzymes (murein hydrolases) 
(Toinasz, 1979) . Low concentrations of antibiotic 
stopped the growth of these mutants but they remain 
viable. Thus the bactericidal effect of the antibiotic 
has been converted to a bacteriostatic effect. The 
tolerant organisms differ from other resistant organisms 
in that they are still susceptible to the growth 
9 
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inhibiting effect of the antibiotic but they are 
tolerant to the lytic action. Tomasz (1979) proposed 
that the direct action of penicillin resulted only in 
inhibition of bacterial growth, while lysis and loss of 
viability of the bacteria were indirect effects 
resulting from an upset in the negative-feedback control 
of the autolytic enzymes (murein hydrolases) after a 
possible interference on the function of one or more . ‘• ‘ _ • . . . . _ . • . 
PBPs. The lysis of bacterial cells following exposure 
to penicillin appeared to require protein synthesis as 
penicillin-treated cells could be "rescued" by treatment 
with sublethal doses of chloramphenicol, which halted 
protein and autolytic enzyme synthesis (Rogers & 
Forsberg, 1971) • All the abovementioned work has led 
to the development of the theory that cells tolerant to 
B-lactams have reduced autolytic enzyme production. 
Sabath and his colleagues (1977) isolated 
tolerant strains of Staph, aureus from seven cases of 
chronic staphylococcal infection and found that these 
isolates were all inhibited by normal concentrations of 
V 
penicillins but could not be killed. The phenomenon of 
tolerance was revealed by^  their normal MICs but very 
high MBCs (128 to 2,000 times the MIC). Most strains 
showed cross-tolerance to cephalosporins but were killed 
at normal rates by gentamicin, cycloserine and 
rifampicin. These tolerant isolates again were shown to 
be deficient in autolytic enzyme activity due to the 
10 
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production of a large excess of an autolysin inhibitor. 
Tolerance in the form described by Sabath et al • (1977) 
was common (about 44% of Staph. aureus isolates from 
bacteraemic patients) and may present a potential 
problem in B-lactam therapy particularly when 
bactericidal antibiotics are required. Penicillin-
tolerant Group B and Group D streptococci isolated from 
patients with relapsing infection have also been 
reported (Allen & Sprunt, 1978； Savitch, Barry & • • • . • • • ‘ • ‘ . •. . 
Hoeprich, 1978)• ” 
Bacterial "persisters" are morphologically 
• ^ 
normal bacteria which survive lethal concentrations of 
one of the penicillins, but whose progeny are fully 
sensitive to these agents. Greenwood (1972) postulated 
that a small percentage of bacteria become "persisters" 
because they are dormant. Once the antibiotic is 
removed persisters revert to a normal growth pattern. 
Since penicillin is only lethal to growing cells and 
that mucopeptide hydrolases are required to initiate 
cell wall growth-points, penicillin inhibition of the 
cell wall autolytic enzymes such as mucopeptide � 
hydrolase, may be the explanation for bacterial 
\ persisters (Hartmann, Holtje & Schwarz, 1972). 
There has been some confusion over the terms 
of tolerance and persistence, but it seems that 
persisters are the occasional cells that survive 
exposure � �penicillin by virtue of a dormant phase of 
progeny shows normal sensitivity, 
11 
whereas tolerant strains have some deficiency in their 
autolytic systems, and whose progeny inherits the same 
trait. Both forms of resistance may have significance 
for the outcome of B-lactam therapy. 
5,2 Enzyme-mediated Resistance 
B-lactam antibiotics have several sites on 
their molecules which are susceptible to attack by a 
number of different enzymes (Figure 8 &Figure 9) 
(Richmond & Sykes, 1973). The resulting alteration of 
the B-lactam molecule reduces or completely eliminates 
the antimicrobial activity of the compound. 
Microbial acylases attack B-lactam antibiotics 
by hydrolyzing the acyl side-chain. Both acylases and 
esterases reduce antimicrobial activity by hydrolysis of 
the N-acyl side-chains and by cleaving the ester bond of 
cephalosporins (Figure 8) (Richmond & Sykes, 1973)• 
The reaction by these two enzymes is considered an 
unimportant mechanism of resistance (Greenwood, 1982) • 
B-lactamases hydrolyse the amide bond of the B-lactam 
� 
ring (Figure 9) • An irreversible reaction then takes 
place releasing an inactive open B-lactam ring and 
regenerating the active eiizyme. B-lactamases are by far 
the most important bacterial enzymes that attack 
lactams because they are common and can mediate 
clinically-significant resistance to many different 3-
lactam antibiotics, 
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6• Transfer of resistance 
The ability to produce B-lactamases is often 
encoded on small, self-replicating cyclic DNA molecules 
called plasmids and are often regarded to be the 
transfer factors (Datta & Kontoinichalou, 19 65). 
Plasmids may encode numerous genes of various phenotypic 
characteristics and may also contain large amounts of 
DNA of unknown functions. The plasmids that encode 
genes for the production of antibiotic resistance are 
. . . . . . ‘ • - ' 
• • " . . . . 
referred to as resistance-plasmids or R-plasmids. 
Usually it is only the R-Plasmids encoding enzymatic 
resistance that can be transferred between bacteria with 
some exception when chromosomal enzymes are involved. 
Plasmids are often able to transfer resistance not only 
to bacteria of the parent species, but also to bacteria 
of a different genera. They may also have the ability 
to confer on the recipient bacterium multiple resistance 
to several different antibiotics, including resistance 
to drugs from different classes. Usually resistance to 
about three common antibiotics is transferred but 
sometimes resistances to many more drugs may b e� 
involved. The spread of this so-called infectious 
\ 
resistance to previously sensitive bacteiria is a major 
reason for the increasing prevalence of acquired 
antibiotic resistance. The coimon types of B-lactamases 
are determined by plasmids and transposons, and their 
transfer within and between species is the reason for 
their wide dissemination throughout the world (Datta & 
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Hedges, 1972; Hedges & Jacob, 1974). 
Transfer of resistance between bacteria of the 
same species, or between different genera, is achieved 
by one of the three mechanisms. The first is 
conjugation, where a resistant bacterium transfers the 
necessary genetic information to a sensitive organism by 
direct contact through a cytoplasmic bridge. Transfer 
occurs in a few minutes and when the recipient cell • . 
multiplies the donated R-plasmid also multiplies and is 
reproduced in the daughter cells. Thus a single 
resistant bacterium can transfer resistance to a large 
population of sensitive microorganisms in a very short 
period of time (Holloway & Asche, 1977) . This is the 
most common mechanism of resistance-transfer in clinical 
isolates of Gram-negative bacteria. 
The second form of transfer is transduction. 
Direct cell contact is unnecessary as the required 
genetic information is transferred by the DNA of a 
bacterial virus or bacteriophage. Once the 
bacteriophage has entered and reproduced within the host 
� 
bacterium, the subsequent rupture of the host cell 
releases many bacteriophages containing R-plasmids. 
These can infect additional bacteria of the same or 
different genera that they acquire R-plasmid-induced 
antibiotic resistance rather than succumbing to the 
viral infection (Holloway & Asche, 1977) • This is the 
common mechanism of transfer of penicillinase-production 
14 
in Staph• aureus. 
Transformation is the third method of 
spreading genetic information and involves incorporation 
of exogenous DNA into the host chromosome. Some species 
like Strep, pneumoniae, Haemophilus influenzae and 
certain Bacillus sp. have been found to be able to 
acquire new genetic characters from the surrounding DNA. 
The classical demonstration of pneumococcal 
transformation was by Griffith in 1928. If a piece of 
DNA encodes antibiotic resistance is passed on to一 the 
host bacterium, the bacteria will become resistant to 
that antibiotic (Cohen, Chang & Hsu, 1972). 
During transfer of genetic information between 
cells, transposition may occur. This involves the 
movement of a portion of DNA (called a transposon) from 
one plasmid to another, or to the chromosome, or to a 
bacteriophage. Transposition is important in the 
dissemination of the resistant genes and can facilitate 
the incorporation of plasmid-born determinants into the 
chromosome (Hedges & Jacob, 1974)• 
Resistance to B-lactams by the production o f � 
B-lactamases is mainly due to plasmid coded enzymes. 
� 
These plasmid-mediated J3-lactamases commonly found in 
Gram-negative bacteria such as E. coli could usually be 
transferred by one of the three aforementioned methods, 
with conjugation being the most common. However, 
transposition may also occur and this has added 





B-lactamases existed long before the discovery 
of penicillin and they are widely distributed in normal 
bacteria. B-lactamases are probably derived from the 
enzymes involved in the control of cell wall formation • . • . . - •. 
and lysis during normal bacterial growth and division, 
including transpeptidases which help in the build up of 
the bacterial cell wall from the outside and 
endopeptidases which erode the cell wall from the 
inside. B-lactamases are probably endopeptidases 
(Duguid, 1978). 
The discovery of B-lactamases can be traced 
back to the observation by Fleming in 1929 that the 
'coli' and 'typhoid' groups of bacteria were resistant 
to penicillin (Fleming, 1929)• This resistance was 
explained when a 'penicillinase' enzyme that inhibited 
the antimicrobial activity of penicillin was extracted� 
from E. coli (Abraham and Chain, 1940). The clinical 
importance of this enzyme first became apparent in the 
1950's, when B-lactamase-producing strains of 
staphylococci appeared and rendered penicillin totally 
ineffective in the treatment of staphylococcal 
infection. The discovery of cephalosporin C in 1953 
. provided an alternative effective therapy for these 
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enzyme-producing strains (Garrod et al. , 1981). The 
enzymatic resistance in staphylococci encouraged the 
development of cephalosporins and B-lactamase-stable 
penicillins such as cloxacillin and methicillin. 
Resistance of Gram-negative bacilli to third-generation 
and other newer B-lactams is now a major clinical 
problem. Several reports of broad-spectrum 3-lactam 
resistance emerged during therapy with a single B-lactam 
(Sanders & Sanders, 1983； Murray et al•, 1983; Olson 
et al • , 1983). Numerous different types of 3-
lactamases have since been discovered that mediate 
lactam resistance in many different species of bacteria. 
This stimulated investigation into new B-lactams active 
against Gram-negative bacteria. 
7 . 2 Classification of 3-lactainase 
6-lactamases of Gram-positive and Gram-
negative bacteria are a large and heterogeneous group of 
enzymes. The enzymes have been classified by several 
schemes and the nomenclature is confusing. The most 
� 
commonly used schemes are those of Richmond and Sykes 
(1973), Matthew (1979), ahd Bush (1989a, b, c)• 
7.2.1 Richmond and Sykes scheme 
Richmond and Sykes (1973) divided B-lactamases 
into five classes (Table 1.1). Their Class � consisted 
of B-lactamases with a high rate of hydrolysis of 
cephalosporins (cephalosporinases)• This large class 
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included the chromosomally-determined B-lactamases of 
pseudomonads and of most of the Enterobacteriaceae. The 
B-lactamases of Proteus spp. and Klebsiella spp. were 
more active against penicillins and their enzymes made 
up Classes 11 and IV respectively. Class ��� comprised 
of the plasmid determined TEM-type lactamases• Class 
V was a heterogeneous group containing enzymes that 
hydrolyse oxacillin and carbenicillin. The has provided 
. “. . ‘ •. an original, thorough and useful classification, however 
there is great heterogeneity within some of the classes 
and that some of the tests (such as enzyme inhibition by 
parachloroinercuribenzoate pCMB) are difficult to perform 
with crude enzyme preparations. Modifications on the 
classification have then been revised as more new 3-
lactamases were identified (Skyes & Matthew, 1976)• 
7.2.2 Matthew scheme 
A major advance in the identification of 3-
lactamases occurred when Matthew et al • (1975) showed 
that specific enzymes could be identified by isoelectric 
focusing. Matthew proposed that B-lactamases could be � 
divided into two major groups employing a three-capital 
\ 
letters system (Table 1.2). Class A were chromosomally-• - ' - • 
mediated and were further subdivided into (a) 
penicillinases, (b) cephalosporinases, and (c) broad 
spectrum i3-lactamases while Class B were plasmid-
mediated enzymes and were divided into (a) the TEM group 
(isoxazolyl-non-hydrolysing) , (b) the OXA group 
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(isoxazolyl-hydrolysing), (c) the PSE group 
(carbenicillin-hydrolysing), and (d) other 
lactamases. 
7.2.3 Bush scheme 
Ambler (1980) proposed a new classification 
scheme for B-lactamases based on the amino acid sequence 
of the active sites of the enzymes as he found that TEM-
1 and TEM-2 differed by only a single amino acid (Ambler 
& Scott, 1978). This system was later extended by 
� , -
Jaurin & Grundstr�(1981) and Bush (1989a, b, c). B-
lactamases were then divided into four groups (Table 
1.3). The Group 1 (CEP-N) contained chromosomal enzymes 
from Gram-negative bacteria. Group 2 were further 
divided into subgroups of 2a, 2b, 2b', 2c, 2d and 2e, 
where the most common enzymes TEM-1 and TEM-2 were 
placed in Group 2b. Group 3 (MET-N) contained enzymes 
from B. cereus 11 and Ps. maltophila LI which required 
bivalent metal cations such as zinc ions, and Group 4 
(PEN-N) included the B-lactamase from Ps. cepacia. 
\ 
7•3 B-lactamases of Gram-negative bacteria 
\ 
7.3.1 Chromosomally-mediated B-lactamases 
B-lactam resistance in Gram-negative organisms 
is often due to high-level production of chromosomally-
mediated B-lactamase. These enzymes inactivate B-lactam 
antibiotics by chemical hydrolysis or by binding 
covalently to the drug to form an inert complex. 
19 
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Klebsiellas are always resistant to ampicillin because 
they constitutively produce broad-spectrum 3-lactamases. 
Chromosomally-mediated enzymes are inducible and are 
structurally or biochemically different from plasmid-
mediated enzymes. Organisms producing this class of 3-
lactamase include Pseudomonas spp., indole-positive 
Proteus spp., Enterobacter spp. and Citrobacter spp. 
(Medeiros, 1984). 
• . 
7.3.2 Plasmid-mediated B-lactamases 
More than thirty plasmid-mediated fi-lactamases 
have been described among Gram-negative bacteria, with 
different isoelectric points and molecular weights 
(Table 2) (Medeiros, 1984; Bush, 1989b, c) . The 
different plasmid-determined B-lactamases have different 
distributions amongst different bacterial genera. The 
largest number of different B-lactamase types have been 
found in Ps • aeruginosa and E. coli (Medeiros et al., . -• . 
1980)• 
The TEM-enzymes are the most common type of 
plasmid-mediated 3-lactamase and are produced� 
constitutively (Matthew, 1979)• The enzyme called 
\ 
was so called because the first organism producing this 
enzyme was isolated from a patient named Temoniera 
(Datta & Kontomichalou, 1965) • The most prevalent 
enzyme is TEM-1. The TEM-1, TEM-2 and the TEM-related 
enzymes have low activities against oxacillin and other 
isoxazolyl penicillins. They can be inhibited by p-
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chloromercuribenzoate (pCMB) but not by sodium chloride 
(NaCl)• The amino acid sequence of TEM-1 and TEM-2 are 
known (Ambler & Scott, 1978) to differ from one another 
by a single amino acid at position 14 and the protein 
can be distinguished by lEF (Matthew & Hedges, 1976) • 
TEM-1 occurred in more than 77% of the organisms studied 
by Matthew and was widely distributed geographically 
(Matthew, 1979) • The genes that produce TEM-1 enzyme 
are easily transferred and are widespread in clinical 
isolates of Enterobacteriaceae (Kontomichalou, 
Papachristou & Levis, 1974). 
The TEM-enzymes could change their 
specificities by mutation. Recently described TEM-1 
enzymes exhibit hydrolysis activity against a broad 
spectrum of B-lactam agents, including penicillins, 
first-generation cephalosporins and even third-
generation cephalosporins (Sougakoff et al., 1988). It 
was thought that the broad-spectrum B-lactamases TEM-3, 
TEM-4, TEM-5, TEM-6 and TEM-7 originated from TEM-2 by 
mutations (Sougakoff et al•, 1988). These enzymes have 
\ 
been found in E. coli, Serratia, Enterobacter and 
Klebsiella (Sirot et al. ,�1988) • The TEM-3 was first 
discovered in Clermont-Ferrand, France, during a 
hospital outbreak of infections caused by K. pneumoniae. 
3-lactam resistance was due to a novel plasmid-mediated 
6—lactamase with high hydrolytic activity against 
cefotaxime and was initially named CTX-1. Subsequently 
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490 TEM-3 (CTX-1) producing strains of 
Enterobacteriaceae were isolated from other French 
hospitals (Sougakoff et al. , 1988)• This enzyme was 
encoded by a 95-kilobase plasmid and characterized by pi 
6.3. Another broad spectrum plasmid-mediated 3-
lactamase was isolated in 1987 from three strains of K. 
pneumoniae that were more resistant to ceftazidime than 
other third-generation cephalosporins. This enzyme had 
pi 5.6 and was encoded by a 150-kilobase plasmid (Petit 
et al. , 1988) . This enzyme was later named as TEM-5 
(Sirot et al. , 1988). TEM-7 was found in the clinical 
isolates of C• freundii from the same hospital where 
TEM-3 was discovered, which had decreased 
susceptibility to ceftazidime (64—fold) and aztreonam 
(16-fold) but not to other third-generation 
cephalosporins (Gutmann et al. , 1988) . This B-
lactamase (pi 5.41) was encoded on a plasmid of about 85 
kilobases. 
SHV-1, which belonged to the SHV group of 
enzymes, was found mainly in Klebsiella. Between 33% 
to 94% of ampicillin-resistant strains produced this� 
enzyme (Simpson et al • , 1980; Simpson et al. , 1986; 
Huovinen et al. , 1988a). SHV-2 is a broad spectrum 
enzyme and is probably derived by a point-mutation from 
SHV-1 (Kliebe et al • , 1985) . This enzyme has now been 
found also in E. coli and Salmonella sp. 
The OXA-enzymes readily hydrolyze oxacillin, 
, methicillin and cloxacillin. The name 'OXA, refers to 
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oxacillin hydrolysis. These enzymes are inhibited by 
NaCl but are not inhibited by cloxacillin. The most 
•-... 
common is OXA-1 which is distributed in many 
Enterobacteriaceae (Matthew, Hedges & Smith, 1979) • 
OXA-2 is present in E. coli, P. mirabilis and some 
other Enterobacteria. OXA-3 has been mainly found in 
Klebsiella sp. (Roy et al., 1983), but rarely in E. 
coli and Ps. aeruginosa (Matthew et al • , 1979) . The 
other OXA-enzymes, OXA-4, OXA-5, OXA-6, and OXA-7 are 
rare. They hydrolyzed oxacillin, methicilliii and 
cloxacillin but differed from OXA-1, OXA-2, and OXA-3 , 
in their substrate profiles, inhibitor reactions, and 
their pis 7.5 to 7.8. OXA-5 (pi 7.62) and OXA-7 (pi 
7.65) had pis close to that of SHV-1 (pi 7.6). They can 
easily be confused with SHV-1 if substrate profiles and 
inhibition reactions are not performed (Medeiros et al •, 
1985). 
The PSE group of enzymes hydrolyze 
carbenicillin. PSE-1 (CARB-2) has been found most 
frequently in carbenicillin-resistant Ps. aeruginosa. 
\ 
The four 'pseudomonas specific' (PSE) B-lactamases were 
so called because they we^e originally believed to be 
mediated by genetic determinants confined to Ps. 
aeruginosa (Hedges & Matthew, 1979)• However, several 
reports indicated that PSE enzymes could also be found 
in Enterobacteriaceae (Medeiros, Hedges & Jacoby, 1982; 
Roy et al., 1983; Livermore, Maskell & Williams, 1984; 
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Levy et al. , 1985) . PSE-3 and PSE-4 (CARB-1) enzymes 
have not been isolated very often (Jacoby & Matthew, 
197 9; Jouvenot et al. , 1983), and the enzymes 
described as CARB-3 and CARB-4 have been found only in 
two strains of Ps • aeruginosa. (Labia et al • , 1981; 
Philippon, Paul & Jacoby, 1986)• 
Another plasm id-mediated fi-lactaiaase name ROB-
1 was isolated from ampicillin-resistant H• influenzae 
(Rubin et al., 1981). In a survey of 161 ampicillin-
. ..... ...... 
resistant H• influenzae strains, 8% of the strains 
produced the ROB enzymes and the rest produced the TEM-1 
enzyme (Daum et al•, 1988). 
BRO-1 isolated from Branhamella catarrhalis 
and Moraxella nonliquefaciens seemed to be the most 
common J5-lactamase in Bran. catarrhalis (Kamme et al., 
1984; Eliasson & Kamme, 1985). 
OHIO, an enzyme isolated from Enterobacter and 
Serratia (Shlaes et al., 1986) has been disseminated 
to other species of Enterobacteriaceae and they were all 
found in Ohio hospitals. 
HMS-1 was found once only in P. mirabills� 
(Matthew, Hedges & Smith, 1979) and the recently 
\ 
detected 6-lactamases LCR-1, TLE-1 were very rare 
enzymes (Simpson et al •, 1983; Medeiros, Cohenford & 
Jacoby, 1985). The AER-1, NPS-1 and SAR-1 were rare 
enzymes isolated from Aeromonas hydrophila (Hedges et 
al” 1985), Ps. aeruginosa (Livermore & Jones, 1986) 
. and Vibrio cholerae (Reid & Amyes, 1986). CEP-2 has 
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been isolated from Achromobacter. (Levesque et al., 
1982). 
7 • 4 13"lactamase inhibitors 
A number of compounds act as potent inhibitors 
or inactivators for a variety of B-lactamases. 3-
lactamase inhibitors can be broadly divided into four 
classes: (a) the metal ion chelators (e.g. EDTA, o-
phenanthroline) ； (b) amino acid modifiers (e.g. pCMB, 
boronic acids)； (c) active-site-directed irreversible 
inhibitors (e.g. clavulanic acid and sulbactam)； and 
(d) B-lactam antibiotics (e.g. aztreonam, moxalactam 
and cefoxitin). 
The advantage of antibiotic combination 
therapy has been well recognized in treatment of 
bacterial infections (Garrod, 1981)• The discovery of 
B-lactamase inhibitors introduced the concept of 
combined therapy with an enzyme inhibitor plus a B-
lactamase-susceptible 3-lactam antibiotic. This drug 
combination restores the antibacterial effectiveness of 
the 3-lactam. To be clinically useful, the inhibitor 
must protect the co-administered B-lactam in the human 
host. Clavulanic acid is structurally similar to the 
basic penicillin nucleus containing a J3-lactam ring 
fused to a second ring system. The major difference is 
the oxygen which replaces the sulphur in the second ring 
system (Figure 7) • It was produced from Streptomyces 
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clavuligerus and was found to be a potent inhibitor of 
different types of 13-lactamases (Reading & Cole, 1977)• 
Sulbactam is a derivative of the basic penicillin 
nucleus. Chemically it is sodium penicillanate sulfone 
(Figure 7) (English et al., 1978) . Augmentin 
(Beecham) is a compound drug consisting of a combination 
of amoxycillin and clavulanic acid while Unasyn (Pfizer) 
is a combination of ampicillin and sulbactam. Augmentin 
and Unasyn depend on clavulanic acid and sulbactam 
respectively to inhibit B-lactamases to protect 
amoxycillin or ampicillin from the attack by the 6-
lactamases. 
The interaction between clavulanic acid and 6-
lactamase is complicated. Clavulanic acid has a close 
structural resemblance to the normal penicillin 
substrate and is in fact recognized by the enzyme active 
site as being a substrate. The 3-lactain ring of 
clavulanic acid is hydrolyzed by the enzyme yielding an 
acyl intermediate. Unlike a penicillin molecule, the 
hydrolysis of the 13 - lactam ring of clavulanate is 
followed by further spontaneous elimination reactions� 
leading to the cleavage of the oxazolidine ring. The 
\ 
acyl intermediate is either relatively stable in its own 
or reacts further with the enzyme to yield a stable 
product, therefore the inhibitory effect is progressive 
and irreversible. Clavulanic acid can inhibit most of 
the plasmid-mediated 3-lactainases including the 
widespread TEM enzymes present in Enterobacteriaceae, 
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pseudomonads, H. influenzae, N. gonorrhoeae, and Bran, 
catarrhalis except the oxacillin (OXA) -type enzymes 
which are marginally inhibited (Reading & Cole, 1977)• 
Chromosomally-mediated J3-lactamases of K. pneumoniae, P. 
mirabilis, P. vulgaris and Bacteroides fragilis, and 
the 3-lactamase of Staph, aureus are all readily 
inhibited by clavulanic acid. On the other hand, the 
chromosomal B-lactamases (cephalosporinases) produced by 
certain Gram-negative organisms such as Morganella 
morganii, Providencia rettgeri, Enterobacter spp. ‘ and 
Ser. marcescens are relatively insusceptible to 
clavulanic acid (Wise, Andrews & Bedford, 1978)• 
The interaction between sulbactam and B-
lactamases is also complex. Initially, there is a 
brief competitive interaction between sulbactam and the 
antibiotic for the fi-lactamase enzyme. After sulbactam 
gains access to the 13-lactamase, irreversible, non-
competitive inhibition occurs, and a stable acylated 
complex between sulbactam and the enzyme is formed. 
Both the J3—lactamase and sulbactam are irreversibly 
� 
destroyed so that sulbactam functions as a "suicide 
inhibitor." Sulbactam has its greatest inhibitory 
activity against Classes II, � � � ， iv, and V 6-
lactamases (Fu and Neu, 1979), which also includes the 
ubiquitous plasmid-mediated TEM enzyme (Richmond-Skyes 
Class � � � a ) , the chromosomally-mediated enzymes of 
Klebsiella spp., and the extracellular staphylococcal 
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enzymes. However, sulbactam does not inhibit Class � 
cephalosporinases, except for that produced by 
Bacteroides fragilis (Fu and Neu, 1979)• 
7•5 Regulation of fi-lactamase production 
7.5.1 J3-lactainase induction 
Certain Gram-negative organisms, including 
Enterobacter, Citrobacter and Providencia spp. , M. 
morganii, Ser. marcescens and Ps. aeruginosa produce 
• ,-
Class � 13-lactainase which is inducible (Lindberg & 
Normark, 1986)• These enzymes have a high affinity 
for the new cephalosporins, and B-lactamase 
overproduction is the most important factor in the 
development of resistance against these drugs (Lindberg 
& Normark, 1986). Enzyme induction is a temporary 
phenotypic adaptation. The structural gene amp C, 
which encodes /^-lactamase production, is controlled by 
a regulatory protein. In the uninduced state this 
protein allows only minimal enzyme synthesis. When an 
inducing agent such as a 13—lac �ain is added, � he 
conformation of the regulatory protein is altered from a� 
repressor to an activated state, allowing free 
transcription of the amp C gene and greatly increasing 
fi—lactamase synthesis. When the inducing antibiotic is 
removed, this system is completely reversed and enzyme 
synthesis returns to its basal level (Hennessey, 1967; 
Richmond & Sykes, 1973; Sykes & Matthew, 1976; Curtis 









I 7.5.2 Mutation to constitutive enzyme production 
High-level constitutive production of -
•j 
I lactamase is the result of a genetic mutation and is 
• irreversible. Because of gene mutation elsewhere on the 
chromosome, the regulatory protein is permanently 
converted to the activated conformation and large 
amounts of 3-lactainase are synthesized continuously 
without the need of an inducer. These mutants are 
referred to as derepressed because they lack the 
repressor mechanism (Lindberg, Lindquist & Normark, 
1986). Organisms producing constitutive B-lactamase are 
true mutants and arise spontaneously at relatively high 
frequencies � 10^) in inducible 6-lactamase 
populations. Derepressed mutants occur at a high 
frequency in Enterobacter spp. and in Ps. aeruginosa 
and can be selected out during B-lactam therapy 
(Shannon, King & Phillips, 1982). 
Depending on the drug used, temporary 3-
lactamase induction may account for treatment failures 
in some patients, which occurs when the inducing� 
antibiotic is unstable to the enzyme produced, or, 
\ 
with double B-lactam combinations, when strong induction 
caused by the first compound antagonizes the labile 
second compound (Nichols & Milne, 1986). However, 
induction is not responsible for the emergence of stable 
resistant strains when B-lactam therapy selects pre-
existing constitutive enzyme producers from a generally 
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•I 
sensitive bacterial population. Reports by King et al. • i 
(1983) and Widemann (1986) showed that B-lactam multi-
...I 
.! ... • >, resistant strains of Ps. aeruginosa could be isolated 
i 
•i 
from patients receiving long term B-lactam therapy. 
These organisms were derepressed for the chromosomally-
encoded B-lactamase. 
7.5.3 B-lactam induced B-lactamase production 
B-lactam induced B-lactamase production can be 
classified into four categories: (1) Labile strong 
inducers, (2) Labile weak inducers, (3) Stable weak 
inducers, and (4) Stable strong inducers. 
Labile strong inducers are represented by 
early 13 - lactams such as benzyl penicillin, ampicillin 
and first generation cephalosporins. B-lactamase 
production is stimulated in the presence of the inducing 
agents which are labile to the enzyme activity and are 
therefore destroyed. (Farmer & Reading, 1987) • 
Cefotaxime and ticarcillin are the examples of labile 
weak inducers for the chromosomal B-lactamase of Ent. 
cloacae (Yang & Livermore, 1988)• � 
Examples of stable weak inducers are the 
\ 
ureidopenicillins carbenicillin, piperacillin, 
azlocillin and mezlocillin, and third generation 
cephalosporins. These B-lactams have a weak inducing 
effect and are only slowly hydrolyzed by small amounts 
of bacterial B-lactamases (Farmer & Reading, 1987) • 
However, a few spontaneous mutations to high-level 
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constitutive production may arise during therapy with 
these weak inducers where the antibiotic eradicates the 
wild type sensitive strains but the high-level producers 
survive. Once they have been selected, the constitutive 
B-lactamase producing strains become the dominant 
population (Shannon, King & Eykyn, 1985)• Stable 
strong inducers include the carbapenem imipenem. The 
antibiotic is almost totally resistant to degradation by 
B-lactamases of all recognized types produced by aerobes 
and anaerobes with the exception of Ps. maltophilla and 
some Bacteroides sp. Even though the enzymes are strong 
inducers, the bactericidal effect still remains strong 
(Kahan et al., 1983; Shannon, King & Eykyn, 1985). 
8. Emergence of resistance due to production of 
B-lactamases 
Significant 13-lactamase production by 
streptococci is extremely rare. Although B-lactamase 
production by Staph• aureus was a major clinical problem 
in the 1960' s, this was largely solved by the 
introduction of the penicillinase-stable methicillin and 
its derivatives. The 15�lactamases of Gram-positive 
species are thus now less interesting than those of the 
Gram-negatives. Gram-negative bacterial infection has 
increased in hospital practice, partly because these 
organisms are resistant to many 3-lactams because of J3-






j been very successful in creating a series of new B-1 ‘ 
lactam drugs even more resistant to Gram-negative 
I bacterial B-lactamases. Nevertheless, clinical isolates 1 I 
I of Gram-negative bacteria resistant to the newer 3-
i I 
j lactam antibiotics continue to appear, and interest in 
I 
Gram-negative B-lactamases remains high. 
8•1 Resistance in staphylococci 
In the early 1940' s over 90% of the 
staphylococci were susceptible to penicillin G, but 
within three years of widespread hospital use, only 25% 
of staphylococci isolated in hospitals remained 
susceptible because of the production of B-lactamase. 
In the community, 85% of the staphylococci remained 
susceptible to penicillin G because of the small amounts 
of penicillin available for out-patient use (Duguid, 
1978) . By the 1960's, however, only 10-15% of 
staphylococci in both hospital and the community, 
remained susceptible to penicillin G, and today, this 
antibiotic is effective against very few strains of 
staphylococci throughout the world (Duguid, 1978) . In� 
more recent years, methicillin-resistance in Staph. 
\ 
aureus has become an increasing problem of hospital 
infection, and this resistance is probably due to � h e 
production of an altered PBP (Brown & Reynolds, 1980)• 
In Hong Kong, 30% of the hospital isolates are resistant 
to methicillin (Cheng & French, 1988) and many are 
multiply-resistant (French et al., 1988). 
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I 8.2 Resistance in haemophili and cronococci 
-i 
1 -.. Before 1970, H • influenzae was considered 
i universally susceptible to ampicillin. The first 
j 
1 clinical isolate of ampicillin-resistant H• influenzae 
J 
appeared in 1974 (Thomas et al. , 1974). Subsequently 
the incidence of resistance has increased worldwide 
(Schwartz, 1978； Lerman, Brunken & Bollinger, 1980). • ‘ . • . • . 
The most common resistance mechanism to ampicillin is 
the production of the TEM-1 /^-lactamase (Medeiros, 
1984) • More than 20% of this strain isolated in USA 
had this property (CDC, 1984) • The problem has 
increased since then, with a reported incidence from 
clinical laboratories in the United Kingdom of 1.60% in 
1977, growing to 6.60% in 1981 (Philpott-Howard & 
Williams, 1982)• Some institutions in the United States 
reported the resistant rate as high as 48% (Thornsberry 
& McDougal, 1982). Resistance to ampicillin and other 
antibiotics has increased markedly in isolates of H• 
influenzae in Hong Kong over the last five years and 
\ 
about 20% of our isolates are now resistant to 
ampicillin. All except on� of the ampicillin-resistant 
strains were found to produce TEM-1 3-lactainase (Ling et 
al., 1989). 
N • gonorrhoeae was originally sensitive to 
penicillin. However organisms resistant to penicillin 





England in 1976 (Phillips, 1976)• These organisms 
j appeared to have spread from the Far East and West 
I 
Africa (Percival et al•, 1976; Ferine et al., 1977). 
Reports from Centres for Disease Control, USA showed 
； I that there were 328 cases found in the United States in 
j . 
1979 rising to a total of 3,424 cases in 1982 (Dillon, 
Pauze & Yeung, 1983) . In Hong Kong, 76% of N. 
gonorrhoeae isolates are now resistant to penicillin 
among which 3 3% are penicillinase producing strains 
(PPNG) and 43% are non—penicillinase producers (Lim, 
personal cominunication). 
8•3 Resistance in Enterobacteriaceae rnon E. coli) 
A study conducted by Simpson et al. (1986) 
identified that 13-lactamases most likely contribute to 
3-lactain resistance in clinical isolates. Two hundred 
and seventeen ampicillin-resistant Gram-negative 
organisms from faecal samples of healthy volunteers in 
Germany, South America and Amman were studied. E. coli 
(59.90%) was the prevalent species, followed by 
Klebsiella spp. (20.30%) and Ent. cloacae (12.00%). > 
One hundred and nine strains produced the R-plasmid-
mediated TEM-1 3-lactamase. In Hong Kong, a study of 
726 Salmonella spp. excluding Sal. typhi, revealed that 
18% were resistant to ampicillin. Forty six percent and 
27% of these ampicillin-resistant strains were TEM-1 and 
OXA-1 producers respectively (Unpublished data)• In a 










I of the isolates were resistant to ampicillin (Ling et 
al., 1988). 
8 • 4 Distribution of J3-lactainases in E. coli 
i 
Geographical distribution of 6-lactamase was 
shown by various surveys of ampicillin-resistant 
Enterobacteria in different parts of the world including 
clinical isolates from France, United States, and 
• • • . 
• . . 
Brazil (Medeiros et al. , 1980) . TEM-1 was the most 
common plasmid-mediated ^-lactamase found occurring in 
159 E• coli isolates in Brazil (81.25%), followed by 
OXA-1 (9.20%), SHV-1 (3%) and PSE-1 (Medeiros et al., 
1980) • Roy et al. (1983) worked with 256 
Enterobacteriaceae isolated from pathological specimens 
in Spain and found that 86 out of 94 (91.50%) E• coli 
were TEM-1 producers. Two types of plasmid-mediated 
enzymes were co-existed in three strains of the E• coli 
isolated. A total of 217 ampicillin-resistant Gram-
negative isolates from stools of healthy volunteers in 
Germany, South America and Amman were investigated� 
(Simpson et al • , 1986), 147 (67.70%) E. coli were 
\ 
isolated as the prevalent species in which 104 (70.70%) 
produced TEM-type B-lactamases, 7 (4.80%) produced 
OXA-1, 2 (1.40%) produced mixed enzymes of TEM-1 + 
OXA-1 and TEM-1 + PSE-1, and 17 (11.60%) produced 
chromosome enzyme only. Huovinen, Huovinen & Jacoby 
(1988a) identified B-lactamases by both colony 
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hybridization and analytical lEF techniques. Among the 
102 unique clinical Gram-negative isolates obtained from 
a hospital in Massachusetts, United States, 48 
I isolates were E. coli isolates in which 40 (83.30%) I .� 
j produced TEM-1, 7 (15%) produced OXA-type enzymes. A 
I 
i 
large study performed in Spain on 1,410 amoxyci11in-
resistant strains of Enterobacteriaceae revealed that 
among 785 amoxycillin-resistant strains of E• coli, 739 
(94.14%) produced TEM-1, 12 (1.53%) produced OXA—1, 11 
(1.40%) produced SHV—1, 11 (1.40%) produced mixed 
enzymes, while only one strain produced TEM-2, and 9 
(1.15%) produced chromosomal B-lactamases (Roy et al., 
1989) • Another study in Spain on 210 B-lactamase 
producing clinical isolates showed that among 107 E • 
coli isolated, 89 (83.17%) produced TEM-1 and 15 (14%) 
produced mixed B-lactamases (Rubio et al., 1989). 
A summary of the global findings of B-
lactamases for ampicillin-resistant E. coli showed that 
TEM-1 is the prevalent enzyme which accounts for 70% and 
up to as high as 95% (Table 3) (Medeiros et al •, 
V 
1980; Roy et al. , 1983; Huovinen, Huovinen & Jacoby, 
1988b,. Roy et al. , 1989 � Rubio et al. , 1989) . The 
second most common enzymes were OXA-1 (3.30%) and SHV-1 
(2.70%). These global findings on the prevalence of B-
lactamases and hence the ampicillin-resistance of E. 
coli showed closed epidemiological similarities, yet 




been extensive survey of ampicillin-resistant E • coli 
j 

















• • • • 一 - — — — • * - • “ 
•I 
MATERIALS AND METHODS 
j 1. Bacterial strains 
j 
I 
\ •j ‘ I 1.1 Standard organisms i 
Standard organisms for antibiotic sensitivity 
testing (Table 4) , standard J3-lactamase producer 
strains with known pis for isoelectric focusing 
controls (Table 5), standard organisms each carrying a 
plasmid for determination of molecular size in gel 
electrophoresis (Table 6) , and E• coli K12 14R525 
which was F_, lactose - ferinenting, resistant to 
nalidixic acid, sensitive to ampicillin and carries no 
plasmid used as the standard organism for conjugation 
experiments, were obtained from ATCC, NCTC, or as 
gifts from Dr. D. Livermore, London Hospital and 
Medical College, U.K. , and from Dr. B. Rowe, Division 
of Enteric Pathogens, Central Public Health Laboratory, 
London, U.K. 
1.2 Clinical isolates 
Selected clinical isolates of E • coll were 
\ 
obtained from specimens at the Prince of Wales Hospital, 
Hong Kong. Each strain was isolated from a different 
patient. The isolates were preserved by two methods: 
one set was grown on Nutrient agar (NA) (Oxoid, 
Basingstoke, England) slants and another set was 




Both were stored at ambient temperature. Bacteria were i 
recovered from storage by growth in Brain Heart Infusion 
(BHI) broth (Oxoid) or on MacConkey (MAC) agar (Oxoid)• 
2• Antibiotics 
Antibiotics used in disk diffusion tests were 
manufactured by Mast, Liverpool, England. Pure 
antibiotics were gifts from the manufacturers (Table 7.1 
to 7.4) or were purchased from the Sigma Chemical Co., 
U.S.A. for determination of minimal inhibitory 
concentrations (MICs). 
3• Media, chemicals and culture conditions 
All the culture media (Table 8), reagents and 
chemicals (Table 9) , and buffers (Table 10) used in 
this study were from various commercial source. 
Unless otherwise stated, all cultures were 
incubated at 37°C. 
4. Bacterial identification and viable bacterial count 
\ 
Bacteria were identified by the API 2 0E (API 
systems, SA, Vercieu, France)• 
Viable bacterial counts were performed by ten-
fold serial dilution of neat, 1 0 一 1 , 1 0 _ 2 , 1 0 一 3 , 1 0 一 4 , 
—5 
10 samples in sterile saline. A standard 0.1 ml of 
each dilution was spread evenly on a NA plate and 











5• Antibiotic sensitivity testing 
5.1 Disk diffusion test 
Antibiotic sensitivity testing was performed 
by the Comparative method (Brown and Blowers, 1978). 
Briefly, bacterial strains were grown to late 
exponential phase in 4.0 ml BHI broth, and subsequently 
plated on 工 s o s e n s i t e s t (1ST) agar (Oxoid) using a rotary 
plater (Denley, England) to give a semi-confluent 
growth of colonies after overnight incubation. Standard 
organism, E• coli NCTC 10418, was incorporated in each 
experiment as control. Based on the recommendation 
(Garrod et al. , 1981), the interpretation of sensitive 
testing results are defined by the following statements: 
"(1) Sensitive: Zone diameter not more than 6 iron smaller 
than that of the control, (2) Moderately resistant: 
Zone diameter of at least 12 mm but more than 6 mm 
smaller than that of the control, (3) Resistant: Zone� 
diameter of 12 mm or less (the disc being 6 mm).“ 
\ 
5-2 Determination of minimal inhibitory 
concentration mxc) 
MICs were determined by the microbroth 
dilution method in microtitre trays, using 1ST broth 
40 
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'1 
(Oxoid) and the MIC-2 000 system (Dynatech Instrument, I 
Inc., California, U.S.A.). Three standard organisms, 
i 
I E. coll NCTC 10418, Staph, aureus NCTC 6571 and Ps. j ‘ 
I aeruginosa NCTC 10662, were incorporated in each 
i 
experiment as controls. Each organism to be tested was 
inoculated in 4.0 ml BHI broth and incubated for 4 h to 
late exponential phase. The bacterial suspension was 
diluted in sterile saline to obtain a turbidity matching 
MacFarland 0.5 standard (giving a bacterial 
. . . . 
Q 
concentration of approximately 1.5 x 10� cfu/ml), and 
then further ten-fold dilution was made in sterile 
saline. MIC-2000 inoculator (Dynatech) was used to 
deliver approximately 10,000 colony forming unit (cfu) 
per microtitre well. The trays were incubated for 18 h, 
and the MICs were taken as the lowest concentrations 
that inhibited visible growth. 
The results of MIC interpretation followed the 
standards of susceptibility by the report of British 
Society for Antimicrobial Chemotherapy (Table 11) (BSAC, 
1988)• Organisms were considered to be resistant to the 
drug concerned if they had MICs greater than t h e� 
breakpoint concentrations (Table 11)• 
\ 
6. Plasmid analysis 
6.1 Transfer of drug resistance plasmids 
The transfer of R-plasmids was demonstrated by 
conjugation experiments (Meynell, Meynell & Datta, 
41 
1968)• The ampicillin-resistant strains were the donor 
and E. coli K12 14R525 was the recipient. The donors 
were nalidixic acid-sensitive while the recipient strain 
possessed a non-transferable nalidixic acid-resistant 
marker located on the chromosome. The two strains were 
grown separately to late exponential phase in 10 ml BHI 
broth. A viable count of the recipient cells was 
performed before the conjugation experiment. Each 
organism (0.1 ml to 0.1 ml) was placed together in 
another 10 ml fresh BHI broth. The conjugation mixtures 
were incubated for 24 h without aeration. 
The transconjugants were selected by plating 
0.1 ml each from the neat, 10 一 1, 10"^ and 10 一 ^  
dilutions of the conjugation mixture on MacConkey agar 
containing nalidixic acid (50 mg/l) and ampicillin (32 
mg/l) • Organisms that grow on this medium were picked 
as transconjugants. The transfer frequency was taken as 
the number of transconjugant colonies per recipient 
cell. Ten transconj ugant colonies from each conjugation 
experiment were picked and tested for their resistance 
to nalidixic acid and ampicillin by the disk diffusion� 
method. The transconj ugants were stored on Dorset's egg 
\ 
slopes at ambient temperature. 
6.2 Molecular studies of plasmids 
The size of plasmid molecule in a bacterium 
was estimated by electrophoresing a crude extract of 





i strains harbouring a standard R-plasmid were used as 
standards for molecular weights (Table 6). 
I . i I 6.2.1 Extraction of plasmid DNA 
i 
Plasmid deoxyribonucleic acid (DNA) was 
extracted by the rapid extraction method of Kado & Liu 
(1981). The cultures to be tested were first streaked 
onto IST agar plates. After overnight incubation cells 
were scraped off from the agar surface with a wire-loop 
and suspended in 100 }J1 of lysing solution (Table 10.1) 
in a 750-pl Eppendorf microcentrifuge tube. The lysate 
was then incubated in a water-bath at 55°C for 60 min. • 
followed by extraction with an equal volume of phenol-
chloroform solution. After centr if ligation (Micro 
Centaur, MSE Scientific Instruments, England) at 
13,000 rpm for 5 minutes. Twenty microlitres of aqueous 
phase was mixed with 5 ； a l of tracking dye containing 
0.07% Bromophenol Blue, 7% SDS (Sigma), and 33.0% 
glycerol (Merck) in Tris-borate buffer (pH 7.0) and was 
then ready for electrophoresis• 
6.2.2 Agarose gel electrophoresis 
Agarose gel electrophoresis was performed with 
0.9% agarose (Sigma) in Tris-borate-EDTA (TBE) buffer 
(Table 10.2). Electrophoresis was performed by a 
vertical apparatus [Bio-Rad Protean 11 (120腿 x 14 0mm 
X 3 mm) slab cell model, California, U.S.A.] in a TBE 






about 2 h or until the tracking dye was just visible at 
the bottom of the gel. The gel was stained with 0.5 
^g/ml of ethidium bromide for 30 min. before exposure 
to ultraviolet irradiation. DNA bands were viewed under 
ultraviolet light (UV) of wavelength 260nm 
(Transilluminator, Ultra violet Product, Inc., U.S.A.) 
and photographed through a red filter (Hoya, Tokyo, 
Japan) using Polaroid T667 (Polaroid, U.S.A.) 
positive/negative black and white films. 
. . . ' . 
. • . . . , 
6.2.3 Molecular size determination � 
The size of DNA fragments in agarose gels was 
determined by comparison with the molecular weight 
standards (Table 6) using a computer programme (Ling et 
al., 1987). 
7• DNA hybridization 
7.1 DNA blotting 
• . 
Two blotting methods were used in the DNA 
hybridization experiments, colony blotting and plasmid 
DNA blotting. In colony blotting, whole cell DNA were � 
extracted and blotted onto a piece of membrane filter; 
\ 
while for plasmid DNA blotting, the plasmid DNA were 
first separated according to their molecular sizes by 
agarose gel electrophoresis, and subsequently 
transferred and immobilized onto a piece of membrane 
filter. A specific DNA probe was labeled with radio-
isotopes. This probe was used to hybridize the DNA 
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[ blotted on the membrane. 
7.1.1 Colony blotting j j 
I standard B-lactamase producing strains and the 
bacterial strains were grown and inoculated onto a 
template microtitre plate. Hybond-N (Amersham, RPN-
303N, England) hybridization transfer membrane of 0.45 
)im-pore-size was placed onto the surface of a 
rectangular Nutrient agar plate. MIC-2 000 inoculator 
was used to deliver the organisms onto the membrane. 
The membrane and agar were marked to ensure correct 
orientation of colonies and then incubated for 6 hours. 
The membrane was removed and placed, colony side up, on 
a pad of absorbent filter paper soaked in denaturing 
solution for 7 minutes. The membrane was neutralized by 
soaking in neutralizing solution for 3 min. and the 
procedure was repeated once again. The membrane was 
washed in 2x standard saline citrate (SSC) (Table 10.3), 
transferred to a dry filter paper with colony side up, 
and allowed to air dry for 1 hour. The membrane was 
wrapped in Saran-Wrap and placed DNA-side down on a UV� 
transilluminator for 5 minutes. 
\ 
7.1.2 Southern blotting 
Plasmid DNA was extracted and separated as 
described in Method Sections 6.2.1 and 6.2.2 except that 
0.7% agarose gel (14.5 x 20.0 cm) was used. 




apparatus (Pharmacia) at 100 volts for 4.5 hours. 
；1 After electrophoresis, the plasmid DNA was 
j • 
I transferred onto Hybond-N membrane of 0.45 严 - p o r e - s i z e 
\ ‘ 
5 
j based on the principle described by Southern (1975) 
•i 
5 j (Figure 10) • The transfer was done by using a VacuGene 
•j 
vacuum transfer apparatus (LKB, Bromma, Sweden). DNA 
! 
within the gel was partially depurinated with 0.25 M HCl 
for 20 min. or until the bromophenol blue dye changed to 
yellow color, hydrolyzed and denatured with 1.5 M NaCl, “. . . . 
0.5 M NaOH for 30 min. , neutralized with 1.5 M NaCl, 1 M 
Tris, pH 7.5 for 30 min., and transferred to membrane 
with 2 Ox SSC for 6 hours. DNA was fixed onto the 
membrane by UV illumination for 5 minutes. 
7•2 Labeling of oligonucleotide probe 
The oligonucleotide probes specific for the 
TEM-1, TEM-2 and OXA-1 B-lactamase genes (Table 12) 
(Ouellette et al • , 1987; Ouellette et al., 1988) were 
purchased from OCS Laboratories, Inc., Texas. The 
oligonucleotide was labeled to a specific activity of 
not less than 10^ cpm/>ig of DNA using a 3'-end labeling� 
kit (Amersham, N4020)• Ten picromoles of 
\ 
oligonucleotide/3' ends, 5 >il of lOx 3'-end labeling 
buffer solution (Table 10.4), 5 )il of enzyme solution 
(terminal transferase) (Table 10.5) and 7.5 }il 
containing 75 )iCi [a -32p]ddATP solution (Amershaiti, 
PB10235) were mixed. The labeled oligonucleotides were 




nucleotides using the pre-packed NAP-5 column 
(Pharmacia) • Labeled probe was used immediately or 
stored at -20^C for a maximum of two days. 
7.3 Hybridization 
Membrane was pre-hybridized for 1 h at 37°C in 
buffer containing 6x SSC, 5x Denhardt's solution (Table 
10.6) , 0.05% sodium pyrophosphate, 100 pjg/itil of 
denatured salmon sperm DNA and 0.5% SDS. Twenty 
millilitres of pre-hybridization solution was required 
for a 1,000 cm^ membrane. Hybridization was carried out 
at 37°C for 16 h in solution containing 6x SSC, Ix 
Denhardt's solution, 100 jag/ml of denatured salmon sperm 
DNA, 0.05% sodium pyrophosphate and 0.5 nanogram/ml 
labeled probe. Another 20 ml of hybridization solution 
was required for a 800 cm^ membrane. Membrane was 
washed three times in 6x SSC, 0.Q5% sodium 
pyrophosphate at room temperature for 5 min. and finally 
washed for 30 min. at 39°C for TEM-1; 37°C for TEM-2 
and 45°C for OXA-1 (Figure 11) as recommended b y � 
Ouellette and his colleagues (1988)• 
\ 
7.4 Autoradiography 
Moist membrane was wrapped in clingfilm and 
exposed to Kodak X-ray film mounted on an intensifying 
screen at -70°C for 2 days. 
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7.5 Re-use of blots 
When the same membrane blot was used to 
hybridize with another DNA probe, the previously 
hybridized probes were removed from the membrane. 
Membranes were not allowed to dry during hybridization 
and washing. The membrane was incubated in 0.4 M NaOH 
at 45°C for 30 inin, and was transferred to 0. Ix SSC, 
0.1% SDS and 0.2 M Tris-HCl, pH 7.5 with an additional 
incubation of 15 minutes (about 450 ml of solution per 
1.000 cm'^  of membrane) . Autoradiography was used to 
determine the complete removal of the probe. 
8 • Detection and screenincr for classification 
of B-lactamases 
8.1 Detection of B-lactamases 
Bacterial B-lactamase production was 
determined using the acidimetric and chromogenic 
substrate (nitrocefin) methods. 
8.1.1 Acidimetric � 
One drop of distilled water (DW) was placed on 
a clean microscope slide and covered with a 3-lactainase 
detection paper strip (Oxoid) so that the paper was 
moistened but not over-saturated. Several colonies were 
streaked onto the dampened strip using a wire loop. 
The presence of a 13-lactainase-producing strain was 
indicated by a colour change from violet to yellow after 
48 
approximately 5 min. on streaked portion of the strip. 
8.1.2 Chromogenic substrate 
The chromogenic substrate (nitrocefin) (Oxoid) 
was yellow in colour which would change to pink within 
one minute upon hydrolysis by the 13-lactamase. The 
presence of 3-lactamase activity was revealed by the 
addition of the nitrocefin to the bacterial whole cells, 
filtrates and the cell extracts. 
8.1.2.1 Whole cell 
Several bacterial colonies were taken with a 
sterile wire loop to make an even suspension in 50 片 1 of 
0.1 M phosphate buffer (PB) pH 7.0. A volume of 50 
nitrocefin solution (200 户 g / m l ) was added to the 
bacterial suspension and the colour change was recorded. 
8.1.2.2 Cell extract and filtrate 
A volume of 10 ； a l of nitrocefin solution (200 
W/ml) was added to 10 ； J 1 of cell extracts or cell 
filtrates in a test tube and the colour change was again 
recorded. ‘ 
8.2 Screening for classification of fi-lactamase 
Organisms were streaked onto IST agar 
containing 16 mg/l aitipicillin and the plates were 
incubated for 24 hours. Several colonies were picked 
and inoculated in 10 ml BHI broth. The tube was put on 
a rotary shaker (New Brunswick Scientific, N.J., 
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U.S.A.) at 100 rpm and incubated for 4 hours. Bacterial 
cells grown in BHI broth were harvested by 
centrif ligation at x2, 000 g (Labofuge, Heraeus, 
Germany) for 2 0 minutes. Cell pellets were washed twice 
with 0.1 M PB (pH 7.0) . Bacterial cells were 
resuspended in 2-0 ml sterile DW. Cells were disrupted 
by sonication in an ultrasonic disintegrator (MSE, 
Soniprep 150) to release the intracellular B-lactamase. 
Cell suspensions maintained at were sonicated for 1 
min. at 15 microns amplitude in four 15-second 
intervals. Cell extracts containing J3-lactainases were 
obtained by centrifuging out the whole cells and debris 
at 13,000 rpm for 5 minutes. The extracts containing B-
lactamase were stored at -20°C (Figure 12)• 
B-lactamase was detected from the cell extract 
by both acidimetric and chromogenic methods with the 
culture media as negative control. Classification of 
the B-lactamases was achieved after analytical 







9• Preparation, purification, qualitative and 
quantitative analyses of the B-lactamase from 
transconiuqants TU117, TB117 and the 
recipient K12 
9•1 Large scale preparation of enzyme 
Organisms (TU117, TB117 and the recipient 
K12) were streaked onto IST agar containing 16 mg/1 • . • • . 
ampicillin and the plates were incubated for 24 hours. 
Several colonies were picked and inoculated into a 
conical flask containing 100 ml IST broth. The flask 
was put on a rotary shaker at 100 rpm and incubated 
overnight. A 1:100 dilution of this overnight broth 
culture was added to a flask containing one litre IST 
broth, placed on a rotary shaker at 150 rpm and 
incubated for 4 hours. A viable cell count was 
performed. Cells grown in IST broth were harvested by 
centrifugation at x2/000 g (RC-3B, Sorvall Instruments) 
for 30 min. at Cell pellets were washed twice with 
• •1 M PB buffer (pH 7.0) . Packed cell pellets were� 
collected by centrifugation, resuspended in 0.1 g per 
ml of Tris-EDTA-sucrose buffer at pH 7.0 before 
performing the viable cell count. Intracellular 3-
lactamases were obtained by disruption of the bacterial 
homogenate from identical wet weights of packed cell 
with approximately the same viable counts from the three 
isogenic strains by a French Pressure Cell (French 
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Pressure Cells and Press； SLM Instruments, Inc., 
U.S.A.). The bacterial suspension was pre-chilled to 
0°C and was pressed twice using the French Pressure Cell 
at 14,000 psi. A viable cell count was performed to 
determine the efficiency of cell breakage. Cell 
extracts were collected by centrifugation at x2,000 g 
for 30 min. at The crude enzyme extract was 
precipitated with 0.4% protamine sulphate by stirring 
with a magnetic stirrer for 60 min. at Cell 
extracts containing B-lactamases were obtained by 
centrifuging out the whole cells and debris at x24,000 g 
(Centrikon, H-401, Kontron) for 60 min. at 4°C. The 
extract (200 ml) was dialyzed against three changes of 
5.0 litres 25 mM Tris buffer pH 7.0 for 72 h at 
The dialysate was freeze-dried (Super Modulgo, Edward, 
U.S.A.), weighed and stored at -20°C for a maximum of 
one week. Protein concentration and 6-lactamase 
activities were measured during every steps of 
preparation (Figure 13) • A summary of procedures 
utilized for purification of B-lactamase by gel 
filtration chromatography and preparation lEF was shown� 
in Figure 14. � 
9.2 Gel filtration 
About 20 g of Sephadex G-lOO gel (Pharmacia, 
Uppsala, Sweden) was allowed to swell in 500 ml of DW 
at 90°C for 2 hours. The swollen gel was then washed 
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several times with degassed 15 mM Triethanolamine-HCl 
(TEA) buffer (pH 7.25) at room temperature before being 
poured into a 200 ml Pharmacia column (1.6 i.d. x 60 
cm) • The sephadex column was equilibrated in 15 mM TEA 
buffer (pH 7.25) at 4°C overnight at a flow rate of 0.5 
itil/min prior to calibration by gel filtration standards 
(Bio-Rad) including Blue dextran (Pharmacia). 
Freeze-dried dialysate reconstituted in DW to 
20 ml was applied to the gel filtration column. The 
protein was eluted with 15 mM TEA buffer (pH 7.25) "at 
4°C and the effluent was monitored using a Uvicord (LKB) 
at OD280 and the result recorded using an integrator 
(Hewlett-Packard, HP3396A, U.S.A.). The effluent was 
collected by connecting the outlet tubing of the column 
to a fraction collector (LKB)• Two hundred fractions 
(30 drops per fraction of 1.4 ml) were collected. A 
drop from each of the collected fractions was tested for 
the presence of B-lactamase by nitrocefin. Protein 
concentration and B-lactamase activities were determined 
for each of the fractions. Fractions with high J3-
lactamase activities were pooled for fur七her � 
purification using preparative lEF. 
9•3 Preparative isoelectric focusing rPIEF^ 
Preparative isoelectric focusing (PIEF) was 
performed with a Rotofor (Bio-Rad)• The focusing 
chamber of the Rotofor is divided into 20 discrete 
�‘ 
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compartments by polyester membranes. These membranes 
stabilize the pH gradient, while allowing the proteins 
to migrate to their isoelectric points (pis)• The cell 
incorporates an internal ceramic cooling finger. 
Separation occurs with the annulus formed by the inside 
wall of the chamber and the cooling finger. The ion 
exchange membranes are used in the Rotofor cell to 
separate the sample from the electrolyte while allowing 
current to pass through and set up the pH gradient. The 
whole system rotated at 1 rpm around the focusing axis 
to eliminate convection and gravitational disturbances. 
Samples from the 20 compartments were collected by 
simultaneous aspiration with a vacuum pump (General 
Electric) into 2 0 test tubes at the end of the run. 
The active enzyme fractions separated by gel 
filtration together with 1% of ampholyte pH 3.5 to 9.5 
(LKB) were made up to 55 ml with DW and added to the 
chamber using a 60 ml syringe. The electrolyte for the 
anode was 0.1 M H3PO4, and the electrolyte for the 
cathode was 0.1 M NaOH. The focusing chamber was 
connected to a power supply system (LKB 2197) set a七 12� 
Watts constant power. The^  cooling finger was connected 
to a coolant outlet of a circulatory cooling bath 
(Neslab Instruments, Inc., Newington, U.S.A.) and the 
temperature was maintained at The voltage was 
increased during the run which usually required 4 h for 
completion. After electrofocusing, 20 fractions of 
sample protein were aspirated by a a vacuum pump and 
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collected in separate test tubes (12 x 75 mm) • The pH 
of each fraction was measured with a semi-micro 
combination electrode (Corning 476540, N.Y., U.S.A.) 
connected to a pH meter (Corning pH/ion meter 150) • 
Protein concentration and 6-lactainase activities were 
determined for each of the fractions. 
9•4 Protein determination 
- • 、. • • • 
The protein assay was a dye-binding assay 
based on the differential colour change of a dye in 
response to various concentrations of protein (Bio—Rad, 
Protein Assay Kit) • The method is based on the 
observation that the absorbance maximuin for an acidic 
solution of Coomassie Brilliant Blue G-250 shifts from 
4 65 nm to 595 nm when protein binding occurs. The 
extinction coefficient (E) of a dye-albumin solution was 
constant over a ten-fold concentration range. Accurate 
quantitation was achieved by selecting an appropriate 
ratio of dye volume to sample concentration. Bovine 
albumin was used as a standard. Several dilutions o f� 
protein standard containing 1 to 25 mg/l were prepared 
for the construction of a standard calibration curve. 
Standard proteins (0.8 ml) and appropriately 
diluted samples were mixed with 0.2 ml Dye Reagent 
Concentrate (Bio-Rad) in a clean dry test tube. The 
mixture was gently inverted several times and allowed to 
stand for 5 minutes. Absorbance versus concentration of 
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standards at OD^^^ (using Absorbance vs. concentration 
mode) was read and plotted by the spectrophotometer 
(Uvikon 860, Kontron, Switzerland)• The concentration 
of the unknowns were read from the standard curve. 
9•5 Qualitative analyses and characterization of 
fi-lactamases 
9.5.1 Analytical isolectric focusing 
The analytical lEF allows the characterization 
-
and differentiation of many types of B-lactamases by-
visual comparison of the banding patterns. The 
procedure involved: semi-quantitative determination of 
enzymes, polyacrylamide gel preparation, isoelectric 
focusing, pH measurement, gel development and 
recording, and isoelectric point determination. 
9.5.1.1 Semi-quantitative determination of 
B-lactamases 
The sample application volume for a 0.75 irun 
capillary polyacrylamide gel was determined semi-
quantitatively with nitrocefin. Enzyme (20 ^1) was � 
added to 150 yil of nitroce^in (20 >ig/inl) , and the time 
(in second) required for a colour change from yellow to 
pink was recorded to determine the volume of sample 
required. The sample enzymes were diluted so that about 




9.5.1.2 Polyacrylamide gel preparation 
Polyacrylamide gels were made with 28 ml of 
stock acrylamide/bis solution [stock solution was made 
up with 22.5 g of acrylamide and 0.5 g of N,N'-
methylene-bisacrylamide (bis) in 250 ml of DW] , 4 0 ml 
of DW, 2.8 g sucrose, 1.5 ml of 40% ampholyte (pH 3.5 
to 10.0 or other narrower range for more precise pi 
determinations) . These ingredients were mixed and then 
degassed for 10 min. using a Buchner flask connected to 
a vacuum pump. Riboflavin (0.6 ml) (100 mg/l), 2 0 pi 
of aininonium persulphate (10% w/v) and 90 片 1 of N,N,N,N— 
Tetra-methylenediamine (TEMED) were added to the 
mixture. The capillary gel casting kit (125 by 260 by 
0.75 mm) (LKB) was used to prepare the gel moulds. The 
glass plates were absolutely clean and dry before use, 
A gel mould was prepared as follows: A few drops of 
water were poured on to the large glass plate and a 
piece of Gel Bond film (LKB) was rolled on to squeeze 
out the excess water. Another thin glass plate with a 
spacer was placed on top of the first plate, leaving 
1 cm free a七 the end. The plates were secured together‘ 
with clamps on the long s^des. Two 0.75-mm gels were 
made by transferring 七 h e polyacrylamide mixture to the 
gel moulds. The mixture was allowed to polymerize for 
2 h at room temperature on the level top of a light box 
fitted with 30 Watts cool-white fluorescent bulbs. The 
thin-layer gels were cast and 七 h e excess moisture was 
removed by blotting with filter paper . for 10 seconds. 
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The gel could be stored for several days at in a 
humid air-tight box. 
9.5.1.3 Isoelectric focusing 
lEF in p o lya cry 1 amide gels was done as 
described by Matthew et al• (1975). Samples 
application pieces (LKB) were placed 2.0 cm from the 
anode position. About 24 sample application strips 
could be applied to the gel. Samples of 20 户 1 were 
delivered by a micropipette on to the sample application 
strips. Standard pi markers (LKB) (Table 9.3) and known 
B-lactamases from standard organisms (Table 5) were also 
placed on the gel to serve as controls. The electrode 
focusing strips were soaked in the appropriate 
solutions, blotted with filter paper, and placed on to 
the corresponding poles. The anode solution used was 
0.1 M H3PO4, and 0.1 M NaOH was used at the cathode. 
The gel was focused by an Ultrophor Electrofocusing 
Unit (LKB 2217) with a Power Supply System set to 10 
Watts constant power and focused for 3 hours. The 
system was connected to a circulatory water bath and the� 
temperature was maintained�at 10°C. 
9.5.1.4 pH measurement 
The pH gradient of the gel was determined with 
a flat surface combination electrode (Corning, 476550) 
connected to a pH meter and readings were taken at i.o 
cm space intervals. 
� ‘ 
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9.5.1.5 Gel development and recording 
9.5.1.5.1 Nitrocefin staining 
The gel was developed by overlaying with a 
sheet of filter paper (104 by 253 mm) saturated with a 
0.05% nitrocefin solution. The major bands appeared 
first and were compared with the standard enzymes. The 
-lactamase band patterns were photographed with a 
Polaroid MP-3 camera through a dark green filter (Hoya) 
with Polaroid type 667 positive instant film. Multiple 
photographs were taken at various times, usually over a 
15 min. period, as minor bands requires a longer time 
than major bands for visualization. The bands were also 
recorded by hand tracing onto a piece of plastic sheet. 
9.5.1.5.2 Silver staining 
The polyacrylamide gel was gently rocked in 
200 ml of fixing solution containing 10% ethanol, 5% 
acetic acid (Bio-Rad, Silver Staining Ki七）• The 
solution was poured off and 200 ml of 0.011 M silver 
nitrate solution was added. The gel was rocked in this 
mixture for 30 min. and rinsed three times with DW. The 
� 
developing (reducing) solution (7.5 g NaOH and 1.9 ml 
of 38% formaldehyde solution made up to 250 ml with DW) 
was added to the gel and rocked for 5 to 10 min. until 
the protein bands were stained. The reaction was 
stopped by drawing off the developing solution and 
replacing this with 5% acetip acid solution. 
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9.5.1.6 Isoelectric point (pi) determination 
The linear relationship of the pH gradient 
against the distance was plotted and the pis of 
different bands were read off from this standard curve. 
9.5.2 Spectrophotometric assay of B-lactam 
substrates 
The B-lactamase assay was carried out 
spectrophotometrically by following the change of the • . • - • • • 
absorption peak upon addition of enzyme to J3-lactain 
antibiotics in 0. 1 M PB pH 7.0. The assay was 
monitored using the in-built computer programs of the 
spectrophotometer which had a thermostatically 
controlled sample holder (Kontron) set at 37°C. 
9.5.2.1 Absorption spectra of i3-lactam 
antibiotics 
The absorption spectra of B-lactam compounds 
were scanned in the wavelength range of 180-700 nm using 
the spectrophotometer. The buffer was 0.1 M PB at pH 
7.0. The peak absorption of each B-lactam was 
determined by the peak detection mode. 
\ 
9.5.2 .2 The mo^ Lar extinction coefficient 
of B-lactam substrates 
The molar extinction coefficients of B-lactam 
compounds were determined by measuring the absorbance of 
the antibiotics at various concentrations. The 
extinction coefficient was the slope calculated from the 
linear relationship between absorbance and concentration 
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(absorbance vs. concentration mode)• 
9.5.2.3 Measurement of J3-lactamase hydrolytic 
activities 
Enzyme (20 ； a l ) was mixed with 1.0 ml of 6-
lactam antibiotic solution (various concentrations from 
0.05 to 0.5 mM) in 0.1 M PB pH 7.0 and the decline in 
absorbance at peak maximum of each B-lactam antibiotic 
following hydrolysis was read. The absorbance run was 
started (time drive mode) just before the solutions 
were mixed. The duration of the mixing time was 
approximately 10 seconds. The initial rate of 
hydrolysis was estimated from the slope of a straight 
line drawn at the initial part of the trace. 
9.5.2.3 Determination of enzyme kinetics 
The Michaelis-Menten kinetic constant Km and 
Vmax values were calculated from the direct linear plots 
according to the me七hods of Wharton & Szawelski (1982). 
The Km is expressed in 声 . The enzymatic unit is the 
quantity of enzyme which is necessary to hydrolyze a � 
itiicromole of substrate per min., at pH 7.0 and 37°C. 
The specific activity was� defined as enzyme unit per 
milligram of total protein. Physiological efficiency 
(PE) was defined by Pollock (1965) as the ratio Vmax/Km. 
、： 
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9.5.3 Molecular weight determination of proteins 
9.5.3.1 SDS-polyacrylamide gel preparation 
The homogeneity and molecular weights of 
proteins were also revealed by discontinuous gel 
electrophoresis. The gel consisted of a resolving or 
separating (lower) gel and a stacking (upper) gel 
(Laeinmli, 1970) . Large volumes of protein were 
concentrated by the stacking gel resulting in better 
band resolution• Molecules were then completely 
separated in the resolving gel. Polyacrylamide gels 
were made by first preparing a stock solution of 29.2 g 
of acrylamide and 0.8 g of N,N'-iriethylene-bisacrylamide 
(bis) in 100 ml of DW. The mixture was filtered and 
stored at 4°C in the dark. 
9.5.3.1.1 Resolving gel 
The gel was prepared with 40 ml of stock 
acrylamide/bis solution, 33.5 ml of DW, 25 ml 1.5 M 
Tris-HCl, pH 8.8, 1.0 ml 10 % (w/v) SDS. These 
ingredients were mixed and then degassed for 10 min. 
using a Buchner flask connected to a vacuum pump. Then � 
500 )Jil 10 % ammonium persu^lphate and 50 ； a l TEMED were 
added to the mixture. The acrylamide mixture was loaded 
onto the gel casting unit kit of Bio-Rad Protean 工 工 Slab 
cell (160 by 200 by 3.0 mm) to a mark on the plate 2 cm 
below the teeth of the comb. The monomer solution was 
overlaid immediately with DW using a needle and 
syringe. The gel was.allowed to polymerize for 2 hours. 
62 
The area above the separating gel was dried completely 
with filter paper before the stacking gel was poured. 
9.5.3.1.2 Stacking gel 
The stacking gel was prepared with 1.3 ml of 
stock acrylamide/bis solution, 6.1 ml of DW, 2.5 ml 
0.5 M Tris-HCl, pH 6.8, 100 10 % (w/v) SDS. These 
ingredients were mixed and then degassed for 10 minutes. 
Then 50 p.1 of 10 % ammonium persulphate and 10 ； a l TEMED 
were added to the mixture. A comb was placed in the gel 
sandwich and the acrylamide mixture was poured until all 
the teeth were covered by solution. The comb was 
removed after the gel was polymerized. The wells were 
rinsed thoroughly with DW. 
9.5.3.2 Electrophoresis 
Sample proteins and standard molecular weight 
markers of MW range 12,3 00 - 78,000 (LKB) (Table 9.3) of 
known concentration determined by protein assay were 
diluted 1:4 with sample buffer. All samples were heated 
at 95°C for 4 min. and 50 � 1 were delivered to the� 
wells. Electrode buffer (pH 8.3) was poured into both 
the upper and lower buffer chambers. The electrical 
leads were attached to the Power Supply System at 70 mA 
constant current and run for 5 hours. The system was 
connected to a circulatory water bath and the 
temperature was maintained at lo^c. 
一 , 
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9.5.3.3 Staining and recording 
Silver staining was performed after 
electrophoresis and the gels were examined and 
photographed on a light box. 
9.5.3.4 Molecular weight determination 
The linear relationship of log^^gMW of the 
proteins against their relative mobilities was plotted. 
The molecular sizes of the unknown protein samples were 
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RESULTS 
!• Collection of organisms 
Five hundred and twenty three non-duplicate 
organisms of Escherichia coli were isolated and 
collected from the clinical laboratory, the Prince of 
Wales Hospital, Hong Kong during 1984-1988. Two 
hundred and twenty two were from blood culture, 100 
were from bile culture and 201 ampici11in-resistant 
-
isolates were selected from urine culture. 
2 • Identification of orcranisms 
All the organisms collected were confirmed to 
be E. coli by the API 20E system. Sixty-nine biotypes 
were categorized according to the API profiles, 
including 31 types of blood isolates, 18 types of bile 
isolates, and 29 types of urine isolates (Table 13). 
One hundred and one strains (19.31%) have an API code of 
5144572 which were the predominant type, and 91 strains 
(17.39%) of API code 5144552 were the second most common 
type. 
Among the 222 kilood culture isolates, 176 
(79.28%) were from community acquired infections and 46 
(20.72%) from hospital acquired infections. Within the 
community acquired infection group, there were 4 7 
biotypes according to the API profiles, the commonest 
API code was 5144552, accounted for 31 strains 
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(17.61%) and followed by the API codes of 5144572 and 
5144512 accounted for 28 (15.91%) and 27 (15.34%) 
respectively. Twenty API biotypes were found in the 
hospital acquired infection group, the commonest API 
code was 5144552 accounting for 12 strains (26%) 
followed by six strains (13%) with API code 5144572. 
3• Antibiotic sensitivity testing 
One hundred and one isolates (45.49%) from 
blood culture and 38 (38.00%) from bile culture . were 
found to be resistant to ampicillin. In addition, 201 
ampicillin-resistant E. coli were collected from urine. 
Among these 340 ampicillin-resistant E• coli, 318 
(93.50%) were sensitive to nalidixic acid. Twenty-seven 
antibiotics, 22 of which were J3-lactams, were tested 
against the 340 ampicillin-resistant E. coli isolates. 
MIC5o, MICgo and the cumulative percentage of 
resistance of the 340 ampicillin-resistant E. coli - • 
against various antibiotics were summarized in Table 14 • 
All these ampicillin-resistant isolates were found to 
have give ampicillin MIC > 8 mg/l and they were also� 
resistant to amoxycillin�(MIC > 8 mg/l) About half 
(171/340) of these isolates were resistant to 
ampicillin/sulbactam, and 41.18% (140/340) to 
amoxycillin/clavulanate• 
When the ampicillin MIC testing was extended 
to a higher concentration (up to 16,384 mg/l), the 
< ampicillin-resistant E. coli could be differentiated 
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arbitrarily into two groups, 72% (245/340) were 
classified as low—level resistance, with MIC < 1024 
• M M 
mg/l, and 28% (95/340) were classified as high-level 
resistance, with MIC > 2048 mg/1 (Figure 15.1) • 
Similarly, when the amoxycillin MIC testing was also 
extended to 16,384 mg/1, the organisms could also be 
differentiated into two groups, 55.29% (188/340) were 
of low-level resistance (MIC < 4096 mg/1) and 44.71% 
(152/340) were of high-level resistance (MIC > 8192 
mg/1) (Figure 15.2). 
About 98% of these organisms were resistant to 
cloxacillin and carbenicillin, nearly 60% to 
piperacillin, more than 85% to cephalothin and 
cephradine, about 75% and 70% to cephaloridine and 
cephalexin respectively. More than 15% of these 
isolates were resistant to cefoxitin and about 2 to 4% 
to cefamandole, cefaclor, cefuroxime and cefoperazone. 
Almost all strains were sensitive to ceftazidime, 
cefotaxime, ceftriaxone, moxalactam, aztreonam and 
imipenem. Sixty percent of the strains were resistant 
to chloramphenicol and 40% were resistant to 
trimethoprim. For the aminoglycosides, about 20% of 
the isolates were resistant to gentamicin and 
tobramycin, but none was resistant to amikacin. A 
comparison of the antimicrobial activities of the 34 0 
ampicillin-resistant E. coli to 13-lactam antibiotics 
(ceftazidime, cefoperazone, cefuroxime, piperacillin 
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and ampicillin/sulbactam) and also to trimethoprim, 
chloramphenicol and aminoglycosides (amikacin, 
tobramycin and gentamicin) were demonstrated (Figure 16 
and 17). 
4• Genetic and molecular studies of ampicillin-
resistant plasmids 
4•1 Transfer of ampicillin-resistant factor 
4.1.1 E, coli K12 14R525 as recipient 
Conjugation of the 318 ampicillin-resistant, 
nalidixic acid-sensitive E • coli isolates to the 
recipient E. coli K12 14R525 (API code 5044552) 
revealed that 229 (72%) strains had their ampicillin-
resistant factors auto-transferred, while 8 9 (28%) 
strains failed to transfer their resistance 
characteristics. The frequency of transfer based on 72 
isolates ranged from 7.1 x 10一2 to 4.5 x 10一 12, the 
autotransfer frequency of a high-level ampicillin-
resistant isolate (U117) and a low-level ampicillin-
resistant isolate (B117) were 1.4 x 10_7, 2.6 x 10_7 
respectively (Table 15a)• 
\ 
4.1.2 Other Enterobacteriaceae 
It was demonstrated that the ampicillin-
resistant factors from both selected isolates of U117 
and B117 were transferable not only to E. coli but also 
to other Enterobacteriaceae namely Salmonella group B, 
Salmonella group E, Shigella sonnei and Shigella 
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flexneri • 
4•2 Plasmid studies of E. coli 
The plasmid profiles of the 318 ampicillin-
resistant strains were randomly selected, analyzed by 
agarose gel electrophoresis, showed that usually more 
than one and up to eight plasmids were present within 
each strain, with molecular sizes ranging widely from 
0.87 to 110 Megadalton (Md) (Table 15b) . However, no 
common plasmid patterns could be established although 
plasmids of similar molecular size were noted in 
different strains. 
Four plasmids were found in the high-level 
ampicillin-resistant isolate (U117) of molecular sizes 
of 82.90, 75.70, 69.90 and 63.80 Md and two in its 
transconjugants (TU117) of 67.90 and 63.80 Md; three 
plasmids were found in the low-level ampicillin-
resistant isolate (B117) of molecular sizes 77.60, 
61.80, and 43.70 Md, while two in its transconjugants 
(TB117) of 77.60 and 43.70 Md (Figure 18). 
Detection and identification of fi-lactamases 
All E. coli were tested for the production of 
B-lactamases by both acidimetric method and chromogenic 
nitrocefin test and only the 340 ampicillin-resistant 
strains tested were found to be positive. 
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5.1 Analytical lEF 
The enzymes of the B-lactamase producing 
strains, identified by analytical lEF, were found to 
be TEM-1 (pi 5.4) (303/340), PSE-1 (pi 5.7) (11/340) or 
OXA-1 (pi 7.4) (10/340) . Five organisms were found only 
to produce chromosomal enzymes and one organism 
possessed an unidentified enzyme which focused at pi 
6.0. In addition 10 strains were found to have co-
existing TEM -1 and PSE-1 in the same organism (Table 
16) • 
5•2 DNA hybridization 
5.2.1 Colony blot hybridization 
The 310 ampicillin-resistant E. coli that 
produced TEM-1 (274), TEM-1 + PSE-1 (10), PSE-1 (11), 
OXA-1 (9), CHR (5) and the unidentified (1) J3-
lactamases had their enzymes re-identified genetically 
by colony blot technique using TEM-1, TEM-2 and OXA-1 
oligonucleotide probes. The TEM-1 probe hybridized with 
267/274 (97.45%) TEM-1 producers and 10/10 (100%) of 
TEM-1+ PSE-1 producers and none of the non-TEM-1 
producers. This TEM-1 probe only failed to detect 7/274 
(2.55%) of the TEM-1 producing strains. The TEM-2 probe 
did not hybridize any of our E. coli isolates. The OXA-
1 probe hybridized with 9/9 (100%) of the OXA-I 
producing E. coli and none of the non-OXA-1 producers. 
Colonies from transconjugant and parent strains TU117, 
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TB117, U117 and B117 hybridized only with TEM-1 but not 
TEM-2 or OXA-1 probes. E. coli K12 14R525 did not react 
with any of these probes (Figure 19). 
5.2.2 Southern blot hybridization 
In addition to colony blot hybridization, 
Southern blot hybridization with TEM-1 oligonucleotide 
probe of plasmids from 44 TEM-1 producers and their 
transconjugants were positive while TEM-2 or OXA-1 were 
negative (Figure 20): Plasmids from B117 with a 
molecular size of 43.70 Md was found to hybridize with 
TEM-1 probe only. Plasmid of the same molecular size 
after transferred to the transconjugant TB117 again 
hybridized with TEM-1 probe. The plasmid of U117 with 
molecular size of 63.80 was positive for TEM-1 probe 
hybridization. Two plasmids from its transconjugant 
TU117 were also positive for the TEM-1 probe, however 
only one was found to be of the same molecular size as 
the parent (63.80 Md) while the second plasmid had a 
size of 67.90 Md different from those found in the 
mother strain (Figure 20)• 
\ 
Characterization of T^ lM-l producing E. coI r 
6.1 Susceptibility testing 
Forty-nine API types could be categorized 
amongst the 303 TEM-1 producing E. coli (Table 1 3 ) . All 
TEM-1 producing strains were resistant to ampicillin 
(MIC > 8 mg/l) and amoxycillin (MIC > 8 mg/l), more 
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than 35% were resistant to amoxycillin/clavulanate (MIC 
> 8 mg/l) and nearly 50% were resistant to 
ampicillin/sulbactam (MIC >8 mg/l) (Table 18). 
Multiple resistance was common in these TEM-1 producing 
E• coli. There were 124 resistance patterns and the 
resistance ranged from one to twelve antibiotics. The 
commonest combinations of resistance were AmpC (8.85% of 
strains), Amp (7.60%), and AmpAugPipCrCorC (4.95%), 
AinpAugPipCrCor (3.30%), AmpAugPipCrCorMaC (3.30%), 
AinpPip (2.87%) (Table 19) . The rest of the 210 (69.31%) 
isolates had heterogeneous resistance patterns. It was 
shown that the 303 TEM-1 producing E. coli with high 
ampicillin MICs resulted in high ampicillin/sulbactam 
MICs with a correlation coefficient of 0.86 (Figure 21). 
Two isolates, one with high-level ampicillin-resistance 
(U117) and another with low-level ampicillin-resistance 
(B117) were found to have ampicillin MIC of 4096 mg/l 
and 128 mg/l respectively. The MIC of these isolates 
and their transconjugants to other antibiotics were 
presented (Table 20) • These isolates and their 
\ 
transconjugants which had similar MICs to ampicillin 
were selected for further Studies. 
6.2 Enzyme kinetic study 
6.2.1 Absorption spectra and molar extinction 
coefficient of B-lactam antibiotics 
Several absorption peaks of B-lactams were 
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found in the ultraviolet and visible region, with 
penicillins at 235 nm, cephalosporins at 254 niti and 
nitrocef in at 386 nm (before hydrolyzed) and 482 nm 
(after hydrolyzed) in the visible region (Figure 22). 
However, the molar extinction coefficient varied from 
0.00158 to 0.028 产 - I c i r T l (Table 17). 
6.2.2 Comparison of the substrate profiles 
The substrate profiles of the high and low 
level ampicillin-resistant isolates (U117 and B117) and 
their two transconjugants (TU117 and TB117) were 
compared using ampicillin as the reference compound 
(rate of hydrolysis = 100) (Table 21) , the order of 
stability of various substrates to the crude enzymes 
isolated from the parents and their isogenic 
transconjugants showed similar substrate hydrolysis rate 
(i.e. cef aitiandole < cephalothin < cephaloridine < 
ampicillin < penicillin G)• It was also noted that the 
hydrolysis rates of ampicillin and cephaloridine of both 
the parents and transconjugants decreased by half and 4-
\ 
fold respectively when sulbactam (5 广 ） w a s added (Table 
21) . ^ 
6.3 Correlation of MICs to fi—lactamase activities 
The B-lactamase activities of 301 TEM-1 
producers isolated clinically and the transconjugants 
(TB117, TU117) strains estimated using nitrocefin as 
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substrate revealed that the lowest B-lactamase activity 
was 89 严 o l of nitrocefin/min found in strain U053 
(ampicillin MIC = 64 mg/1) while the highest B-lactamase 
activity was 39,285 ； a m o l of nitrocef in/min found in 
strain U114 (ampicillin MIC = 8192 mg/l) . It was shown 
that isolates with high ampicillin MIC resulted in 
increasing activity of 13-lactamase while the low-level 
resistant organisms produced low activity of B-lactamase 
with a correlation coefficient of 0.75 (Figure 23). 
7• Isolation, quantitation and characterization of 
fi-lactamases isolated from, three E• coli strains 
Two strains, U117 (ampicillin MIC = 4096 mg/1, 
sulbactam MIC = 64 mg/1, ampicillin/sulbactam MIC = 
64/64 mg/l) and B117 (ampicillin MIC = 128 mg/1, 
sulbactam MIC = 16 mg/l, ampicillin/sulbactam MIC = 4/4 
mg/l) were selected for further studies on their B-
lactamases based on their differences in MICs to 
ampicillin and other B-lactams (Table 20) • Isogenic 
pairs were obtained by transferring the plasmid to the 
recipient K12 {E. coli K12 14R525) which has an� 
ampicillin MIC = 4 mg/l.�The isogenic transconjugants 
TU117 (ampicillin MIC = 4096 mg/l, sulbactam MIC = 64 
mg/l, ampicillin/sulbactam MIC = 32/32 mg/l) and TB117 
(ampicillin MIC = 128 mg/l, sulbactam MIC = 32 mg/l, 
ampicillin/sulbactam MIC = 4/4 mg/l) had no significant 
differences in MICs of ampicillin and other J3-lactains 
compared with the parent strains (Table 20) • The 
74 
� 
transconj ugants and the recipient were used in the 
following studies of 6-lactamases. A summary of the 
preparation and purification of lactamase with 
quantitation were given in Table 22 and Table 23 
respectively. 
7•1 Preparation of B-lactamase 
The harvested culture of K12, TB117 and TU117 
contained packed cells of wet weight 13.90 g, 13.30 g 
and 13.70 g respectively with viable count of 3.60 x 
IqIO cfu/ml, 4.10 X IqIO cfu/ml and 4.20 x cfu/ml 
respectively (Table 22)• The bacterial homogenates were 
obtained by French Pressure disruption, with cell 
breakage efficiencies over 99.99% (Table 22). The crude 
cell extracts collected were found to have total protein 
of 1349.58 mg, 796.16 mg and 1216.16 mg respectively. 
No 3-lactainase activity was detected in K12 • Specific 
B-lactamase activities of TB117 and TU117 were 166.42 
and 715.37 严 o l of ampicillin/min/ing protein 
respectively, with total activity of 132,500 and 
� 
870,000 >imol of ampicillin/min (Table 23) . Cloudy white 
suspensions were observed �when 0.4% protamine sulphate 
was added to the crude cell extracts. The post-protamine 
sulphate precipitated fractions of TB117 and TU117 were 
found to have 687 .72 and 851. 44 mg total protein 
respectively; and specific ^-lactamase activities of 
259.92 and 952 . 79 >iitiol of ampicillin/min/mg protein 
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respectively (Table 23) . After dialysis, the 
dialysates contained 500.32 mg and 779.62 mg of protein 
and specific B-lactamase activities of 237.35 and 981.25 
^mol of ampicillin/min/mg protein respectively (Table 
23). These dialysates after lyophilization resulted in 
dry weight of 1.80 g for K12, 2.00 g for TB117 and 1.70 
g for TU117 (Table 22). These freeze-dried preparations 
of TB117 and TU117 were reconstituted in DW to have 
purity of 1.37-fold and 1.76-fold with respect to their ’ ...• • 
crude cell preparations (Table 23) , and these were 
stored at -20°C for later analysis. 
7 • 2 Purification of i^-lactamases 
7.2.1 Gel filtration chromatography 
The reconstituted lyophilized crude enzyme 
preparations were loaded onto a Sephadex G-lOO column as 
the first purification step. Two hundred fractions 
(1.40 ml per fraction) were collected, with protein 
concentrations and B-lactamase activities estimated for 
each fraction (Figures 24 to 2 6 and Table 23) • Peaks 
containing proteins with 13-lactainase activities were� 
noted with apparent molecular weights of 22,000 daltons 
\ 
for TB117 (Figure 25) and TU117 (Figure 26) , no 13-
lactamase activity peak could be detected in K12 (Figure 
24) • The peak fractions of TB117 (45 to 68) (Figure 25) 
and TU117 (45 to 65) (Figure 26) were pooled for further 
purification and analyses. 
The pooled active fractions of TB117 and TU117 
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after gel filtration had specific 3-lactainase 
activities of 2571.48 and 4331.63 ^mol of 
ampicillin/min/mg protein, total protein of 40.83 and 
103.42 itig, and total activities of 105,000 and 448,000 
^mol of ampicillin/min respectively (Table 23) . These 
fractions were examined by analytical lEF. It was shown 
that only one single active band focused at pi 5.4 in 
TB117 (lane 3) and TU117 (lane 1) (Figure 31) but not in 
K12. However, some satellite bands could be seen near 
the major band and weak bands at the alkaline region 
from these two preparations. It was also observed that 
some faint diffused bands were found at the alkaline 
region of K12 • When the gel was stained by silver 
staining method, more than six bands were seen in both 
TB117 (lane 5) and TU117 (lane 3) (Figure 32) . The 
purification of the B-lactamase at the end of this step 
was more than 15-fold for TB117 and 6-fold for TU117 
(Table 23). However, only the fractions from TB117 and 
TU117 were further purified because no detectable 
lactamase activity was found in the K12• 
\ 
7.2.2 Preparative isoelectric focusing 
\ 
Pooled fractions containing B-lactamase 
activity of TB117 and TU117 were subjected to 
preparative lEF. After focusing for 4 h at 4°C by the 
Rotofor, 20 fractions were collected. Protein 
concentration and B-lactamase activity were measured for 
each fraction. It was noted that the protein peaks 
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containing enzyme activity of TB117 (Figure 27) and 
TU117 (Figure 28) were mainly found in the pH range of 
5.0 to 6.0. The fractions of TB117 and TU117 with 
lactamase activity were pooled and found to have 
specific B-lactamase activities of 53,017.24 and 
56, 431.92 严ol of ampicillin/itiin/mg protein； total 
protein of 0.46 and 3.84 mg; and total activities of 
24,600 and 217,000 ^mol of ampicillin/min respectively 
(Table 23) . The purification of the B-lactamases of 
TB117 and TU117 was found to be about 300-fold and 80-
fold respectively (Table 23). 
Summaries of specific 6-lactamase activities 
and total ii一lactamase activities in different stages of 
enzyme purification were shown in Figure 29 and 30. 
7•3 Characterization of the purified B-lactamases 
The 3-lactainases of TB117 and TU117 after the 
final purification step of preparative lEF were further 
characterized by analytical lEF and SDS polyacrylamide 
gel electrophoresis. 
7.3.1 Isoelectric point 
\ 
After analytical lEF was performed on the 3-
lactamases purified from TB117 and TU117, activity 
staining by nitrocefin revealed that only one single 
band at pi 5.4 was present for the preparations from 
TU117 (lane 2) and TB117 (lane 4) (Figure 31)• When the 
enzymes purified from TU117 and TB117 were mixed and 
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analyzed by the same system, again only one single band 
focused at pi 5.4 could be visualized (lane 7) (Figure 
31). When the same gel was examined using the silver 
stain, purified J3-lactamases from TB117 (lane 4) and 
TU117 (lane 2) again revealed only one single band 
focused at pi 5.4 (Figure 32). 
7.3.2 Molecular weight assessment 
When the crude cell extracts from TB117 and 
TU117 were analyzed by SDS-PAGE, numerous bands could 
be revealed. The number of bands decreased when the 
extracts were subjected to purification by gel 
filtration and preparative lEF. After the final 
purification step, the SDS-PAGE analysis of the 
lactamase purified from both TB117 (lane 3) and TU117 
(lane 2) showed that they both contained a major band of 
molecular weight 22,000 daltons (Figure 33) . The same 
major band was found when the purified enzyme fraction 
from the isogenic pair of TU117 and TB117 were mixed 
(lane 1) before the SDS-PAGE analysis (Figure 33)• 
7.3.3 Enzyme kinetic study 
\ 
When the kinetic parameters (Km, Vmax and PE) 
of various B-lactam substrates to purified B-lactamases 
from TB117 and TU117 were compared (Table 24). 
There were no significant differences in substrate 
profiles between the B-lactamases purified from TU117 
and TB117. The order of stability of substrates to the 
enzymes were the same (i.e. cefoperazone < cefamandole < 
�‘ 
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1. Epidemiology of ampicillin (or amoxycillin) -resistant 
E, coli 
Ampicillin-resistant bacteria is commonly 
found in environmental water and clinical isolates. 
French and his co-workers (1987) reported that 49% of 
the faecal Gram-negative bacteria isolated from six 
fresh-water streams in populated areas of Hong Kong were 
ampicillin-resistant. These organisms showed a high 
prevalence of antibiotic resistance and were usually 
multiply resistant. Among the clinical isolates of 
Gram-negative bacteria, E• coli is particularly common. 
A recent five year study in our hospital revealed that 
the most common organism isolated from 2,211 episodes of 
septicaemia was E• coli, accounting for 28% of all, and 
44% of Gram-negative isolates (French et al., 1990) • 
The present study at the Prince of Wales 
Hospital, Hong Kong from 1984 to 1988 on 523 non-
duplicate E. coli isolate from blood, bile and urine 
revealed that 47 types were identified from their API 
profiles. The most commoh API profile from blood was 
5144552 followed by 5144572. There was no correlation 
between these biotypes from patients with hospital 
acquired or community acquired infections. 
Some amoxycillin-resistant E. coli strains 
were also reported to be resistant to the combination of 
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amoxycillin and clavulanate. Martinez et al. (1987) 
noticed an increasing incidence of 
amoxycillin/clavulanate-resistant E, coli (MICs 1 6 + 8 
mg/1 of amoxycillin + clavulanate) in Madrid. It was 
thought that the frequency might be more than one-third 
of the amoxycillin-resistant E• coli. Williams et al. 
(1988) also observed that some amoxycillin-resistant E, 
coli were less susceptible than others to 
amoxycillin/clavulanate. Among the E. coli strains 
isolated in this study, 340 were found to be 
ampicillin-resistant. Susceptibility testings of these 
ampicillin-resistant organisms to 27 different 
antibiotics revealed that they were also amoxycillin-
resistant. Furthermore, about 50% of these isolates 
were also resistant to ampicillin/sulbactam and 41.18% 
to amoxycillin/clavulanate. Change of resistance were 
comparable with the reports in the above-mentioned 
literature. However further demonstration on the 
ampicillin/sulbactam-resistant rate is seeming higher 
than the amoxycillin/clavulanate-resistant rate, and is 
probably due to different in resistance mechanism. � 
In addition to our findings on the resistance 
\ 
of ampicillin-resistant E. coli to ampicillin/sulbactam 
and amoxycillin/clavulanate, about 98% and 60% of the 
organisms were resistant to carbenicillin and 
piperacillin respectively. Among the first generation 
cephalosporins (cephalothin, cephradine, cephaloridine 
and cephalexin) , approximately 70 to 90% of these 
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strains were also resistant. The second generation 
cephalosporins (cefamandole, cefaclor and cefuroxime) 
were rather effective as only 2 to 4% were resistant. 
The third generation cephalosporins (ceftriaxone, 
cefotaxime and ceftazidime), imipenem and aztreonam 
were by far the most effective antibiotics against these 
ampicillin-resistant E• coli strains as less than 1% of 
them were resistant. 
Other antibiotics showed different patterns of 
resistance. About 60% were resistant to chloramphenicol 
and 37% to trimethoprim. Among the aminoglycosides, 17% 
and 23% were resistant to tobramycin and gentamicin 
respectively, while none was resistant to amikacin. 
Based on these epidemiological findings (Table 14) and 
the comparative antimicrobial activities (Figure 16 and 
17), a second or third generation cephalosporin, 
aztreonam, imipenem or amikacin would be the drug of 
choice for the treatment of infections caused by 
ampicillin-resistant E. coli. 
There were 124 resistance patterns ranging 
\ 
from one to twelve antibiotics. The most common was 
AmpC (8.85%) with descendihg order of common appearance 
of Amp (7•60%), AmpAugPipCrCorC (4.95%), 
AmpAugPipCrCor (3.30%), AmpAugPipCrCorMaC (3.30%) and 
AmpPip (2.87%) (Table 19) . However, these patterns 
only accounted for 30% of the isolates while the rest 
were heterogeneous. This heterogeneity was further 
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supported by plasmid profile analysis which revealed 
that all the ampicillin-resistant E, coli possessed 
different number of plasmids with different molecular 
sizes, with no common pattern established for 
ampicillin-resistance. When 303 TEM-1 producing E. coli 
were analyzed using similar API biotypes, antibiotic 
resistance patterns and plasmid profiles, the same 
heterogeneity was observed. Similar technique used by 
Yeung (1987) also showed that there was no correlation 
between plasmid profile and gentamicin-resistance in E. 
coli isolated from hospital and sewage. 
2• Distribution of fi-lactamases in ampicillin-resistant 
E. coli 
Organisms producing B-lactamase have become 
increasingly important. Different regions had only 
slight variations in the distribution of B-lactamases 
(Table 3). All the ampicillin-resistant E. coli tested 
in this study produced fi-lactamases. six different B-
lactamase types were identified among the 340 J3-
lactamase producing strains. TEM-1 was the most� 
predominant type of B-lactamase found in ampicillin-
resistant E. coli in Hong Kong since nearly 90% of our 
isolates produced this enzyme. A similar rate of 82 to 
94% was observed by Medeiros et al. (1980), Roy et al• 
(1983 and 1989), Huovinen et al• (1988a), and Rubio et 
al. (1989). 
Distribution of B-lactamases in ampicillin-
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resistant E• coli by analytical lEF revealed that 3.20% 
were PSE-1 producer. This finding of PSE-1 not being 
confined to Ps. aeruginosa but also present in other 
Enterobacteriaceae was also supported by Medeiros et al. 
(1980) . Ten of our strains had two enzymes (TEM-1 + 
PSE-1) co-existed in the same organism and this co-
existence of PSE-1 and TEM-1 in E. coli has only been 
reported by Simpson et al • in 1986. In our study, the 
prevalence of PSE-1 producers (3.20%) and TEM-1 + PSE-1 
co-producers (2.90%) were the highest when compared with 
other reports in the literature (Table 3)• These higher 
incidence may be related to different 3-lactamase 
production among different geographical locations. 
TEM-2 B-lactamase, found closely related to 
TEM-1, was reported to be present in E. coli and in 
other Enterobacteriaceae elsewhere (Medeiros et al., 
1974)• However, no TEM-2 producing E. coli was found 
in our study. Another study in our hospital on 163 
ampicillin-resistant Proteus mirabilis showed that TEM-
1 was again the commonest B-lactamase detected (50%)； 
but TEM-2 was the second most common (21%) followed by 
PSE-2 (20%) (Unpublished^ results)• TEM-2 enzyme 
therefore is common in our local Enterobacteriaceae 
isolates. However, the absence of this enzyme in E. 
^^^^ in this region indicates again the possibility of 
minor difference in 5-lactainase distribution 
geographically. 
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Five (1.47%) of our isolates produced 
chromosomal-mediated (CHR) B-lactamase with pis greater 
than 8.0. These organisms were resistant to ampicillin 
(MIC = 32 to 128 mg/l) and cephalothin (MIC > 64 mg/l) 
but sensitive to carbenicillin (MIC < 32 mg/l). Similar 
findings were reported by Medeiros, Kent & O'Brien, 
(1974) as organisms producing the CHR were usually 
resistant to ampicillin and cephalothin but more 
susceptible to carbenicillin. Failure in transfer of 
this ampicillin-resistance suggested that this enzyme 
may be chromosomal in origin or on non-transferable 
plasmids. 3-lactamase was also present in ampicillin-
sensitive E. coli. When enzyme was isolated from 
ampicillin-sensitive (ampicillin MIC = 4 mg/l) E. coli 
K12 14R525 in high concentration, it could give 
positive reaction to nitrocefin and focus at pi > 8.0. 
This shows that even an organism is reported to be 
sensitive to ampicillin, it can still produce a small 
amount of chromosomal B-lactamase. Chromosomal 5-
lactamase was detected in our study using analytical lEF 
in all the E. coli isolates as diffuse bands at pi >� 
8.0. Similar observations about chromosomal-mediated 
enzyme were reported (Medeiros, Kent & 0,Brien, 1974). 
3. Correlation between level of resistance and 
fi-lactamase activity 
Williams et al • (1988) noticed that some 
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amoxycillin-resistant E. coli were less susceptible than 
others to amoxycillin/clavulanate (MIC = 32+16 mg/l 
amoxycillin + clavulanate)• These resistant strains 
produced about three times as much TEM 6-lactamase as 
"standard" strains. Similar resistance phenomenon was 
observed as half of the ampicillin-resistant E. coll in 
this study were resistant to ampicillin/sulbactam. The 
ampicillin/sulbactam-resistant isolates had initial 
ampicillin MIC.of 丄 128 mg/l (highest concentration in 
routine ampicillin MIC testing)• An extended range of 
ampicillin MIC from 128 to 16,384 mg/l was performed to 
study the effect of the B-lactamase inhibitors in the 
reduction of ampicillin MIC. These strains could be 
differentiated arbitrarily into two groups, with 72% 
(245/340) classified as low-level resistant (MIC > 16 to 
1024 mg/l) and 28% (95/340) as high-level resistant (MIC 
> 2048 mg/l). Similarly, when amoxycillin MIC was 
ex七ended to 65,53 6 mg/l, the amoxycillin-resistant E. 
coli could also be differentiated into two groups, 
56.76% (193/340) were low-level resistant (MIC > 64 to 
4096 mg/l) and 43.24% (147/340) were high-level � 
resistant (MIC > 8192 irig/l)�. 
It was suggested that both clavulanate and 
sulbactam should restore antibacterial activity of 
ampicillin against ampicillin-resistant strains of E. 
coli (Aldridge, Sanders and Marier, 1986)• However, 
our finding showed that about half of the ampicillin-
resistant strains were also ampicillin/sulbactam-
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resistant (MIC > 8 mg/l) and 41.18% were resistant to 
amoxycillin/clavulanate (MIC >8 mg/l)• The organisms 
with high ampicillin/sulbactam MICs correlated with 
high-level of ampicillin-resistance (r = 0.86). Thus 
ampicillin or amoxycillin MICs were proportional to 
ampicillin/sulbactain or amoxycillin/clavulanate MICs. 
This indicates a resistance mechanism possessed by the 
organisms to these J3-lactam and B-lactamase-inhibitor 
combinations. About 36% of amoxycillin-resistant E. 
coli isolates in Hong Kong were resistant to 8 mg/l 
amoxycillin in the presence of clavulanate (French & 
Ling, 1988). 
Among the 303 TEM-1 producers, nearly 50% 
were resistant to ampicillin/sulbactam and 35% to 
amoxycillin/clavulanate with high- and low-level 
resistance (Table 18). However, the ampicillin MICs of 
the TEM-1 producers varied from 64 to > 8192 mg/l and 
the total 3-lactamase activities of these strains ranged 
from 90 to 40,000 ； a i t i o l of nitrocefin/min. When the MICs 
of high-level and low-level resistant isolates were 
\ 
investigated for their TEM-1 fi-lactamase activities, it 
was shown that high- and loW-level resistance correlated 
with high- and low-TEM-1 /3-lactamase activity (r = 0.75) 
and there was a 400-fold increase in enzyme activity in 
the high-level resistant strains compared with the low-
level resistant counterparts. However, exceptional 
cases of resistant isolates with low-enzyme activity 
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exist, probably due to biological variations. 
4• Plasmid-mediated TEM-1 B-lactamase 
4•1 Transfer of resistance 
The following mechanisms allow resistance to 
be transferred and spread in the Gram-negative hosts: 
the capability of resistant determinants located on the 
plasmid of conjugal transfer among a wide range of 
bacterial families (Datta & Hedges, 1972) ； the ability 
to transpose between replicons (Hedges & Jacob, 1974); 
and the possibility of plasmid transformation (Cohen, 
Chang & Hsu, 1972) • The ampicillin-resistant genes were 
widely spread among our E• coli strains since they were 
not confined to a specific plasmid type. Conjugation 
experiments revealed that ampicillin-resistant 
characteristics were transferred to a bacterium 
originally without a plasmid and ampicillin-sensitive. 
Seventy-two percent of the resistant strains had the 
resistance plasmids autotransferred to the sensitive 
strain and the frequencies of autotransfer could reach� 
as high as 7 x ICT^. � This high efficiency of 
resistance transfer probably explains the maintenance of 
large number of resistant organisms in the community. 
More resistant organisms will be expected to be present 
in the hospital environment. This "infectious 
resistance" is therefore particularly important in 
causing nosocomial infections. 
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All ampicillin-resistant E• coll in this study 
produced B-lactamase and possessed plasmids. Once the 
transconjugants acquired one to several plasmids carry 
the resistance, they became B-lactamase producers 
showing ampicillin-resistance similar to their parent 
strains by the MIC values (Table 20). 
The inconsistency of the ability in conjugal 
transfer of plasmid carrying the ampicillin-resistant 
factors have been reported (Martinez et al. , 1989; 
Shannon et al • , 1990) . In our study of conjugal 
transfer experiments, we found that 72% of the 
organisms contained transferable plasmids. It was also 
observed that not all plasmids present in the mother 
strains could be transferred to the recipients (Shapiro, 
1983) • When ampicillin/sulbactam-sensitive (B117) and 
ampicillin/sulbactam—resistant (U117) isolates with the 
group containing transferable plasmids were selected for 
conjugation experiments, three plasmids were present in 
B117 and only 2 were transferred to TB117 ； four 
plasmids were present in U117 and only 2 were acquired 
\ 
by TU117. One of the plasmids in TU117 had molecular 
weight of 67.90 Md whicfi was not identical to the 
parent. It was postulated that part of the DNA molecule 
of this smaller plasmid (67.90 Md) had been lost from a 
bigger plasmid (69.90 Md) of the parent during 
conjugation. Further experiments by restriction 
endonuclease digestion on the plasmid DNA will be 
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required to find out the exact origin of this new 
smaller plasmid. However, this incomplete transfer did 
not affect the phenotypic expression of B-lactamase 
probably because the deletion site or the missing 
plasmid did not contain the B-lactamase gene. This 
hypothesis was substantiated by results from the 
Southern blot hybridization using TEM-1 probe. 
In Hong Kong, Salmonella typhi is invariably 
sensitive to ampicillin. In this study, plasmid-
mediated ampicillin-resistance was common in E. coli 
which is a common intestinal flora. Transfer of the R-
plasmids to other intestinal pathogens may result in the 
emergence of ampicillin-resistant pathogens such as Sal. 
typhi. As demonstrated in this study, the R-plasmids 
could be transferred to E. coli easily and they were 
also capable of transferring to other Enterobacteria. 
Both the salmonellae and shigellas were able to acquire 
the R-plasmids from the ampicillin-resistant E. coll. 
The antibiotic sensitivity patterns of transconj ugants 
were similar to their parent strains. 
X 
4.2 Identification of B-lactamases bv DNA Hybridization 
\ 
Although 工 E F has been extremely useful in the 
characterization of B-lactamases produced by Gram-
negative bacteria, colony blot hybridization is faster 
and can analyze a large number of clinical isolates. 
The TEM-1 and TEM-2 probes are very specific (Ouellette 
et al•, 1988). None of our strain could be hybridized 
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with TEM-2 probe and this was consistent with the 
analytical lEF results which confirmed that TEM-2 enzyme 
was not present in our E. coli isolates. One out of 
two transferred plasmids from the ampicillin/sulbactam-
sensitive transconjugant (TB117) and two plasmids from 
ampicillin/sulbactam-resistant transconj ugant (TU117) 
were hybridized by Southern blot hybridization using 
specific oligonucleotide TEM-1 probe. The finding that 
B-lactamase determinants can be carried on multiple 
number of different plasmids, or as multiple genes on a 
single plasmid was also observed by Shannon et al • 
(1990). Unfortunately only TEM-1, TEM-2 and OXA-1 
probes were available in this study, therefore the 
enzyme could not be genetically verified if the organism 
possessed the enzyme other than those three. A false 
negative result may occur if a mutant enzyme is 
translated from a different gene sequence, and this 
might accounts for the probe failure on the seven 
isolates in this study (Figure 19)• A false positive 
result may also occur if the gene probe hybridizes with 
the organism that possesses the B-lactamase gene that is 
not expressed phenotypically (Ouellette et ai • , 1988). 
The short shelf-life and radioactive hazard are other 
pitfalls of DNA hybridization. However, this technique 
still provides an alternative method of identifying the 
B-lactamase gene. 
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5• Mechanism of high-level resistance 
Biochemical experiments were used to elucidate 
the mechanisms of high-level ampicillin-resistance and 
hence the mechanism of resistance to 
ampicillin/sulbactam and amoxycillin/clavulanate. The 
epidemiological data in ampicillin-, 
ampicillin/sulbactam-, and amoxycillin/clavulanate-
resistant E• coli suggest that there is a distinction in 
the phenotypic expression of ampicillin resistance at 
different MIC levels. This difference in ampicillin 
resistance related well with B-lactamase production and 
the high-level of ampicillin resistance also correlated 
with the ampicillin/sulbactam and 
amoxycillin/clavulanate resistance. 
5•1 Selection of resistant strains 
Among the ampicillin-resistant E• coli, two 
groups were categorized according to their MIC values, 
low ampicillin-resistance (MIC < 1024 mg/1) , and high 
ampicillin-resistance (MIC > 2048 mg/l) • One organism 
\ 
from each group of high and low resistance to ampicillin 
were selected to look for�the factor responsible for 
ampicillin/sulbactam- and amoxycillin/clavulanate-
resistance. The ampicillin-resistant genes were 
transferred to the recipient E. coli K12 14R525 which 
harboured no plasmid and with ampicillin MIC = 4 mg/l. 
The two transconjugants TB117 and TU117 expressed the 
93 
same phenotypic characteristics as the recipient with 
the exception of ampicillin-resistance. These 
transconjugants were structurally identical to the 
recipient K12 thus eliminating the resistant factors 
contributed by outer membrane barrier (Osborn & Wu, 
1980) and penicillin-binding proteins (Spratt, 1978)• 
This isogenic pair of transconjugants was found to 
produce the same TEM-1 enzyme based on analytical lEF of 
the crude enzyme preparation, their similar resistance 
patterns towards other 13-lactams (Table 20) and Southern 
blot hybridization of their plasmids which reacted only 
with the TEM-1 oligonucleotide probe (Figure 20)• 
The substrate profiles of the crude enzymes 
from these two TEM-1 producers and their transconjugants 
were compared. Substrate profile can be used as a 
first-line parameter in the classification and 
characterization of J3-lactamases since different 3-
lactamases will have different activities on B-lactams 
(Bush & Sykes, 1986; Bush 1989a, b, c) • These four 
strains showed similar substrate profile characteristics 
which indicated that they were probably producing the� 
same enzyme (Table 21)• However, the crude enzymes of 
ampicillin/sulbactam-resistant strains (U117 and TU117) 
produced an activity of 3-lactainase which is five time 
more than those produced by the sensitive strains (B117 
and TB117). 
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5•2 ^-lactamases preparation and purification 
A good cell breakage technique is required to 
release enzyme without denaturation. Ultrasonic 
treatment, osmotic shock, freeze-thaw and sand 
grinding have been compared for their abilities to 
disrupt and release B-lactamase from bacterial cells 
(Simpson & James, 1982)• For small volume, ultrasonic 
treatment was found to be the most effective and rapid 
technique, and was used for screening and rapid 
qualitative analysis of J3-lactamase in our clinical 
isolates which usually amounted to a sample volume of 
less than one millilitre. 
When ultrasonic disintegration of bacteria was 
employed to liberate intracellular B-lactamases, there 
was rapid and irreversible inactivation of B-lactamases 
due to overheating, especially for the type-Id-J3-
lactamase from Ps • aeruginosa, while none of the B-
lactamases was inactivated by French Press disruption 
(Mett, Schacher & Wegmann, 1988)• Thus French Press 
disruption method was chosen to release the 6-
\ 
lactamases from E. coli K12 14R525, TB117 and TU117 in 
this study. A large sample volume of up to 100 ml of 
lolO cfu/ml bacterial suspension could be handled easily 
in a single disruption. No heat was generated during 
this procedure resulting in no loss of enzyme 




Several groups of researchers had attempted to 
purify B-lactamases from various Gram-negative bacteria 
using single-step chromatofocusing (Werner & Erne, 1983) 
or by a combination ultracentr if ligation, preparative 
electrofocusing and chromatographic techniques (Datta & 
Richmond, 1966; Yamagishi et al., 1969; Minami, 
工 n o u e & Mitsuhashi, 198 0; laconis & Sanders, 1990) • 
The enzymes purified were claimed to reach homogeneity. 
B-lactamases purified by a single step chromatofocusing 
had 4 to 16-fold purification (Werner & Erne, 1983)• 
When the B-lactamases were purified using 
chromatography and electrophoresis, 188-fold 
purification was obtained from Aeromonas hydrophlla 
(laconis & Sanders, 1990)； 140-fold from Enterobacter 
cloacae GN7471 (Minami et al., 1980)； 261-fold from 
coll penicillinasel4 (Yamagishi et al • , 1968) ； and 
80-fold from penicillinase of E. coli (Datta & Richmond, 
1966). 
The purification of TEM-1 produced by TU117 
and TB117 using protamine sulphate precipitation, 
centrifligation and dialysis, followed by gel filtration� 
chromatography and preparative lEF showed that the 
\ 
recovered enzymes were purified 78 and 318-fold 
respectively. Further analyses on the final enzyme 
preparation revealed that they were pure, with 
identical single activity band which focused at pi 5.4 
(Figure 31, 32) and both had molecular weight of 22,000 
daltons (Figure 33) . Furthermore, mixing of purified 
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enzymes from TB117 and TU117 revealed only one band on 
analytical lEF and SDS-PAGE (Figure 33) • These 
physicochemical findings showed that the enzymes from 
TB117 and TU117 were indistinguishable. Both TB117 and 
TU117 produced B-lactamases with almost identical 
specific enzyme activities of 53017.24 and 56431.92 ； a m o l 
of ampicillin/min/mg protein respectively, this further 
substantiated that no significant difference occurred in 
substrate profiles (Table 24) • It was therefore 
confirmed that the two organisms of different 
sensitivity patterns to ampicillin/sulbactam and 
amoxycillin/clavulanate did produce the same TEM-1 B-
lactamase. Since the transconjugants were found to be 
structurally identical, the only difference contributed 
to their differences in ampicillin-resistance has to be 
on the production of i3-lactamase. As the B-lactamases 
were identified to be the same enzyme of TEM-1, it is 
hypothesized that the resistance mechanism of these two 
isolates would be based upon the difference in total 
activities, and thus quantitative analysis of enzyme 
production is warranted. 
\ 
5.3 Hvperproduction of B-lactamase 
The reduction in susceptibility to B-lactam 
antibiotics with or without 13-lactainase inhibitors was 
suggested to be a result of hyperproduction of 3-
lactamase (Martinez et al•, 1987; Reguera et al., 
< 
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1988; Williams et al. , 1988; Page et al. , 1989; 
Shannon et al. , 1990) . Five amoxycillin/clavulanate-
resistant E• coli which produced plasmid-mediated TEM-1 
B-lactamases have been studied by Martinez et al. (1987) 
to elucidate this phenomenon of hyperproduction of 
lactamase. The resistance to this combination of 
antibiotics was transferable to recipient E• coli HBlOl 
by conjugation and transformation. All the resistant 
transconjugants or transformants were found to produce 
four to fifty times more TEM-1 B-lactamase than the 
recipient HBlOl which contained one single gene of TEM-1 
located on the plasmid pMM4::Tn3. It was further found 
that a strain contained a plasmid pUC8 harbouring more 
than 50 copies of the TEM-1 gene also showed high-level 
resistance to amoxycillin/clavulanate (MIC = 64/32 
mg/1). The number of TEM-1 genes or total amount of B-
lactamase also correlated with the level of 
amoxycillin/clavulanate MICs. Further study by this 
group revealed that gene dose could affect the level of 
resistance to B-lactam antibiotics susceptible to TEM-1 
3-lactamase since high-level of B-lactam resistance、 
could result from a strain carrying a multicopy plasmid 
that coded for TEM-1 than for strain with a monocopy 
plasmid (Reguera et al•, 1988). 
It was also observed by Williams et al• (1988) 
that among the amoxycillin-resistant strains of E• coli, 
some were less susceptible to amoxycillin/clavulanate 
than others. They studied multi-resistant E• coli in an 
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outbreak and separated the organisms into two groups 
based on the difference of plasmid-mediated TEM 3-
lactamase activities. The amoxycillin/clavulanate 
resistance strain was found to produce three times more 
enzyme activities than the sensitive strains. These 
hyperproduction of B-lactamase was reported to give 
positive correlation to the phenotypic resistance 
expressed by the figures of MIC against different B-
lactam antibiotics. 
Page and his associates (1989) also supported 
the hypothesis that the hyperproduction of B-lactamase 
could reduce susceptibility to the antibiotic 
combinations of amoxycillin plus clavulanate. In their 
studies, the activities of crude extracts of B-lactamase 
produced by E• coli strains (JT4 and JT160) were 
measured, and compared with strain JT39 (ampicillin 
MIC= 128 mg/l) • All the strains were found to produce 
TEM-1, with strain JT4 showing slightly elevated 3-
lactamase activity and strain JT160 producing more than 
two to three times in activity than JT39. Eventually 
the strain with elevated levels of TEM-1 were all、 
classified as hyperpi^oducers (Page, personal 
coinmunication) • 
The hypothesis of hyperproduction of 3-
lactamase in reducing amoxycillin/clavulanate activity 
by E. coli was elucidated by Shannon et al• (1990) by a 
genetic approach. Using restriction enzyme digestion 
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and DNA-DNA-hybridization techniques, it was found that 
during transfer of plasmids there were re-arrangement of 
plasmid DNA associated with hyperproduction of B-
lactamase. This resulted in an increased number of TEM-
1 gene copies (i.e. an amplification mechanism) and 
eventually an increase in phenotypic resistance and an 
approximately five times increase in TEM-1 activities. 
It was concluded that the bacterial resistance was based 
on the overproduction of B-lactamases and these 
lactamases were good clavulanate inhibitors and their 
overproduction ensured extra inhibition of amoxycillin. 
Our findings also supported the hypothesis of 
hyperproduction of B-lactamases in reducing 
susceptibility of the organism to i3-lactam antibiotics. 、 
It was demonstrated in this study that not only could 
hyperproduction of TEM-1 B-lactamase reduce the 
susceptibility of E • coli to amoxycillin/clavulanate, 
but also to ampicillin/sulbactam and other 
cephalosporins. Although Southern blot hybridization 
experiments on the B-lactamase carrying plasmid were not 
quantitative, it did provide an exclusive proof that 、 
the plasmid from both transconjugants carried only the 
\ 
TEM-1 gene. Our findings supported the hyperproduction 
hypothesis using classical physicochemical approach as 
we have demonstrated that the ampicillin-resistant, 
ampicillin/sulbactam-sensitive isolate (B117) and the 
ampicillin-resistant, ampicillin/sulbactam-resistant 
isolate (U117) produced the same TEM-1 enzyme but in 
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different quantities both in crude extracts and in 
purified preparations. A firm proof of the identity of 
the enzyme was achieved as the phenotypic characteristic 
of resistance was transferred to the same recipient and 
the TEM-1 -lactamase from the transconjugants were 
purified to homogeneity before analyses. 
It was therefore concluded that together with 
genetic information, the physicochemical results from 
this study confirmed that the mechanism of high-level 
resistance of ampicillin, ampicillin/sulbactam, 
amoxycillin/clavulanate and perhaps other i3-lactams were 
all due to hyperproduction of B-lactamase. Whether the 
production is from multicopy of genes in a single 
plasmid (i.e. gene amplification) or from multicopy of 
plasmid carrying single B-lactamase gene warrants 
further investigation. As commented in the literature, 
quantitative problems should be analyzed by quantitative 
methods and that the use of biochemical techniques for 
the evaluation of the quantity of enzyme produced by the 
bacteria will remain necessary as complementary tests in 
epidemiological studies of antibiotic resistance、 
(Martinez & Baquero, 1990)^ . 
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SUMMARY AND CONCLUSIONS 
The epidemiological findings on plasmid-
mediated B-lactamase producing E. coli showed no major 
differences when compared to reports from other parts of 
the world, with TEM-1 as the predominant enzyme. 
However, minor differences such as high incidence of 
PSE-1 producers and the absence of TEM-2 existed. The 
ampicillin-resistant E• coli could be further classified 
to high- and low-resistance groups according to their 
MICs, with level of resistance correlating with 
quantitative enzyme productions. Ampicillin/sulbactam-
sensitive (low-level ampicillin-resistant) and 
ampicillin/sulbactam-resistant (high-level ampicillin-
resistant) organisms were found to possess transferable 
plasmids encoding TEM-1. The TEM-1 from 
ampicillin/sulbactam-sensitive and ampicillin/sulbactam-
resistant isogenic transconjugants were proven to be of 
the same identity by physical and biochemical methods 
and by DNA-DNA hybridization. Quantitative analyses on 
the enzyme production from the isogenic pairs concluded 、 
that ampicillin/sulbactam resistance mechanism of E. 
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* * * • 
Table 1. Classification schemes of B-lactamases 
Table 1•1 Richmond and Sykes Scheme 
Five classes of fi-lactamases: 
I. Cephalosporinase - chromosoitia 1 ly determined 
J3-lactamase of Enterobacteriaceae and 
Pseudomonas. 
11. fi-lactamases of Proteus and Klebsiella. 
工 工 I . Plasmid-determined TEM-type B-lactamases. 
IV. B-lactamases of Proteus and Klebsiella. 
V. Heterogeneous grouping - Oxacillin, 




Table 1.2 Matthew scheme 
Class A chromosomally-mediated 
a. penicillinases 
b. cephalosporinases 
c. broad spectrum 3-lactamases 
Class B plasmid-mediated 
a. TEM group 
isoxazolyl-non-hydrolysing 
b. OXA group 
isoxazolyl-hydrolysing 






Table 1.3 Bush scheme 
Group 1 
CEP-N • 






















Bacillus cereus 11, Ps• maltophilla LI 
Group 4 
PEN-N 
Ps. cepacia ‘ 
\ 
120 
Table 2. The isoelectric points (pi) and molecular 
weights (MW) of some standard 
B-lactamases 
Standard pi MW 
i3-lactamase 
AER-1 5.90 22,000 
CEP-2 8.10 36,200 
HMS-1 5.20 21,000 
LCR-1 6 . 5 0 4 4 , 0 0 0 
OXA-1 7.40 23,300 
OXA-2 7.45 44,600 
OXA-3 7.10 41,200 
OXA-4 7.50 23,000 
OXA-5 7.62 27,000 
OXA-6 7.80 40,000 
OXA-7 7.65 25,000 
PSE-1 5.70 26,500 
PSE-2 6.10 12,400 
PSE-3 6.90 12,000 
PSE-4 5.30 32,000 
ROB-1 8.10 * 
SHV-1 7.60 17,000 
TEM-1 5.40 22,000 
TEM-2 5.60 23,500 
TEM-3 6 . 3 0 * 
TEM-7 5.41 * 
TLE-1 5.55 19,800 






Prevalence of different types of plasmid-mediated 



































































































































































































































































































































































































































































































































































Table 4. Standard organisms for antibiotic sensitivity 
testing 
Organism Reference number 
E. coli ATCC 25922 
E. coli ATCC 35218 
Staph, aureus ATCC 25923 
Ps. aeruginosa ATCC 27853 
E. coli NCTC 10418 
Staph• aureus NCTC 6571 
Ps. aeruginosa NCTC 10662 
ATCC: American Type Culture Collection 




Table 5. Standard 3-lactamase producer strains 
Organism* Strain Enzyme 
number produced 
E. coli K12 R6K TEMl 
E. coli K12 RPl TEM2 
E. coli K12 RGN238 OXAl 
E. coli K12 R46 0XA2 
E. coli K12 R57B 0XA3 
E. coli K12 R99 HMSl 
E. coli K12 RIOIO SHVl 
Ps. aeruginosa PU21 RPLll PSEl 
Ps. aeruginosa. PU21 R151 PSE2 
Ps. aeruginosa PU21 RMS149 PSE3 
Ps. aeruginosa PU21 PMG19 PSE4 
* Kindly supplied by Dr. D. Livermore, London 




Table 6. Standard organisms containing plasmid 
of known molecular sizes 
Bacteria* Strain Plasmid Molecular size 
number number (Md) 
E. coli 28R823 TP116 143.7 
E. coli RT641 # 59-4 
E. coli 40R660 S-a 25.9 
E. coli 40R268 TP125 64.0 
E. coli 40R646 RPl 37.8 
E. coli 48R623 TP193 20.2 
E. coli 40R448 TP129 77.6 
E. coli 48R626 X 40.0 
E. coli 34R193 TP120 ‘ 31.7 
* Kindly supplied by Dr. B. Rowe, Division of 
Enteric Pathogens, Central Public Health 
Laboratory, London, U.K. 




Table 7. Tables of antibiotics for in vitro 
sensitivity testing 
Table 7.1 Penicillins 
Antibiotic MW Source 
Amoxycillin 365.41 Beecham 
Ampicillin 349.41 Sigma 
Carbenicillin 378.40 Sigma 
Cloxacillin 435.89 Sigma 
Methicillin 380.42 Sigma 
Oxacillin 401.44 Sigma 
Penicillin G 334.39 Glaxo 
Piperacillin 517.55 Lederle 
Table 7.2 Cephalosporins 
Antibiotic MW Source 
Cefaclor 367.81 Lilly 
Cefamandole 462.50 Lilly 
Cefoperazone 645.67 Pfizer 
Cefotaxime 455.46 Hoechst 
Cefoxitin 427.45 Merck, 
Sharp & Dohme 
Ceftazidime 546.57 Glaxo 、 
Ceftriaxone 554.57 Roche 
Cefuroxime 424.38、 Glaxo 
Cephalexin 347.39、 Sigma 
Cephaloridine 415.49 Sigma 
Cephalosporin C 415.42 Sigma 
Cephalothin 396.44 Sigma 
Cephradine 349.40 Squibb 
Moxalactam 520.47 Lilly 
126 
Table 7 . 3 Other 3-lactain compounds 
Antibiotic MW Source 
Aztreonam 435.40 Squibb 
Clavulanic acid 199.16 Beecham 
Imipenem 299.34 Merck, 
Sharp & Dohine 
Sulbactam 255.22 Pfizer 
Table 7.4 Other antimicrobial agents 
Antibiotic MW Source 
Amikacin 585.61 Bristol 
Chloramphenicol 323.13 Sigma 
Gentamicin 477.60 Sigma 
Nalidixic acid 232.20 Sigma 
Netilmicin 475.59 Scherling 
Tobramycin 467.52 Sigma 




Table 8. Culture media 
Medium Source 
Nutrient agar (NA) ) 
Nutrient broth (NB) ) 
工 s o s e n s i t e s t (IST) agar ) Oxoid, Basingstoke 
Isosensitest {iST^ broth ) England. 
Brain heart infusion (BHI) broth ) 
MacConkey agar (MAC) ) 





Table 9. Tables for reagents, chemicals, accessories 
and equipments 
Table 9.1 Materials used for analytical isoelectric 
focusing (lEF) and SDS-polyacrylamide gel 
electrophoresis (SDS-PAGE) 
Chemical & Accessory Catalogue Source 
No. 
Acrylamide 1820-101 LKB 
Ammonium persulphate A-6761 Sigma 
Ampholine (40%) pH 3.5 to 9.5 1809-001 LKB 
Ampholine (40%) pH 5.0 to 8.0 1809-026 LKB 
Glycerol Merck 
Glycine 1830-802 LKB 
-methylene-bisacrylamide M-7256 Sigma 
(BIS) 
,N‘-Tetra-methylenediamine T-8133 Sigma 
(TEMED) 
Riboflavin R-4500 Sigma 
B-mercaptoethanol LKB 
Bromophenol Blue BDH 
Capillary gel casting unit 2117-701 LKB 
(125丽 X 2 60丽 X 0.75inin) 
Ultrophor electrofocusing unit 2217 LKB 
Filter paper S-161-26 LKB 
(104im X 253 mm) 
Gel bond film LKB 
Rotofor Bio-Rad、 
Protean 11 Slab Cell Bio-Rad 
(200丽 X leomin x 3im) 
Sodium hydroxide (NaOH) 、 BDH 
Phosphoric acid (H3PO4) Merck 
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Table 9.2 Materials used for plasmid analysis 
Chemical Source 
Agarose (Type I, low EEO) Sigma 
Ethylenediamine tetracetate, 
disodium salt (EDTA) BDH 
Polyethylene glycol Sigma 
Boric acid BDH 
Sodium acetate BDH 






Table 9.3 General purpose reagents 
Reagent Catalogue Source 
No. 
Blue Dextran Pharmacia 
Coomassie Blue R250 1840-101 LKB 
Hydrochloric acid (HCl) Merck 
Molecular weight standards 
(MW range 12,300-78,000) 1860-102 LKB 
Nitrocefin Oxoid 
pi markers 
(pi range 4.7-10.6) 18060-201 LKB 
Protamine sulphate P-4380 Sigma 
Protein assay kit Bio-Rad 
Sephadex G-100 17-0060-01 Pharmacia 
Sodium dodecyl sulphate (SDS) Sigma 
Sucrose Sigma 
Triethanolamine 8379 Merck 
Tris (hydroxymethy1) methylamine 
細 工 S) 1830-801 LKB 




Table 9.4 General purpose equipments and accessories 
Item Model Source 
No. 
Centrifuge Labofuge Heraeus 
Centrifuge RC-3B Sorvall, Instruments 
Centrifuge lEC, International 
Circulatory water bath Neslab 
Column K16 Pharmacia 
Cuvettes (plastic) 67.742 Sarstedt 
Cuvettes (quartz) 2410-2 Kontron 
Flat surface combination 
electrode 476550 Corning 
Fraction collector 2 070 LKB 
Freeze dryer Edward 
French Press SLM, Aminco 
Heating block Sybron 
Integrator HP3396A Hewlett Packard 
MIC-2 000 System Dynatech 
Micropipette Eppendorf 
pH/ion meter 150 Corning 
Power supply 2197 LKB 
Rotary plater Denley 
Semi-micro combination 
electrode 476540 Corning 
Shaker New Brunswick Scientific 
Spectrophotometer Uvikon 860 Kontron 
Transilluminator TL-33 Ultra Violet Product 
Ultrasonic disintegrator MSE 




Table 10. Tables of buffer solution 
Table 10.1 Lysing solution for plasmid extraction 
3% Sodium dodecyl sulphate (SDS) 
SOmM Tris 
Adjusted to pH 12.6 by adding 
1.6 ml of 2N NaOH 
Table 10.2 Tris-Borate-EDTA (TBE) buffer 
Concentrated stock solution (5x) 
Tris base 54g 
Boric acid 270g 
0.5M (EDTA) pH8.0 20inl 




Table 10.3 Standard saline citrate (SSC) 
Concentrated stock solution (2Ox) 
NaCl 175.3 g 
Sodium citrate 88.2 g 
Dissolve in DW 800.0 ml 
Adjusted pH to 7.0 with 10 N NaOH 
Adjusted volume to 1 litre with DW 
Dispensed into aliquots 
Sterilized by autoclaving 
Table 10.4 Buffer solution for 3‘-end labeling 
100^1 concentrated 3'end labeling buffer contains: 
Sodium cacodylate, pH7.2 
Cobalt ( 工 工 ） c h l o r i d e 
Dithiothreitol 





Table 10.5 Enzyme solution for 3‘-end labeling 
5户1 aliquot contains : 
Terminal transferase (10 units) 
in buffer solution, pH7.0 
Potassium phosphate 
Glycerol 
Nuclease-free bovine serum albumin 
2-mercaptoethanol 
(Component of the 3‘-end labeling kit, 
Amersham, N.4020) 
Table 10.6 Denhardt's solution 
Concentrated stock solution (50x) 
Ficoll 5 g 
Polyvinylpyrrolidone 5 g 
BSA (Pentax Fraction V) 5 g 
Made up to 500ml with DW 
Filtered through a disposable Nalgene filter, 





Table 11. MIC interpretive standards of susceptibility 




Amoxycillin/clavulanic acid (2:1) 8 




Cephalothin ( 4) 
Cephradine 4 
Cephaloridine ( 4) 
Cephalexin ( 4) 








Ceftriaxone ( 8 ) 
Aztreonam 8 








* Taken from British Society for Antimicrobial 
Chemotherapy (BSAC), 1988. 
# Breakpoint values in brackets are calculated 
according to the BSAC formula 
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Table 12. The nucleotide sequence of oligonucleotide 
probes 
Probe nucleotide sequence 
TEMl 5 ' CCC AAC TGA TCT TCA 3' 
TEM2 5' CCC AAC TTA TCT TCA 3‘ 
OXAl 5 ' CCA AAG ACG TGG ATG 3' 
Oligonucleotide probes were purchased from 




Table 13. API codes of E, coli 
API All Blood Urine Bile TEM-1 producer 
Code (69)* (31) (29) (18) (49) 
0144512 1 1 0 0 1 
0144572 2 1 0 1 1 
1044102 1 1 0 0 0 
1044132 1 0 0 1 1 
1044152 1 1 0 0 0 
1044412 1 0 0 1 0 
1044452 1 0 0 1 1 
1044512 4 2 1 1 2 
1044542 1 1 0 0 1 
1044552 18 12 3 3 11 
1044562 2 2 0 0 0 
1044572 6 4 1 1 2 
1144152 1 1 0 0 0 
1144512 2 1 0 1 1 
1144552 15 6 4 5 6 
1144572 7 3 1 3 3 
3044572 1 0 0 1 1 
4044102 1 1 0 0 0 
4044512 2 2 0 0 0 
4144412 1 1 0 0 0 
4144512 2 1 1 0 1 
4144532 5 4 1 0 4 
4144562 1 1 0 0 0 
4144572 1 0 0 1 1 
5044102 1 0 1 0 1 
5044142 1 0 1 0 1 
5044152 5 3 2 0 2 
5044452 3 1 1 1 2 
5044500 1 0 1 0 1 
5044502 2 0 1 1 1 
5044510 1 0 0 1 0 
5044512 8 1 5 2 5 
5044530 1 0 0 1 0 
5044532 2 1 0 1 1 
5044542 3 1 0 2 1 、 
5044550 1 1 0 0 0 
5044552 54 16 20 18 29 
5044562 1 1 、 0 0 2 
5044570 1 0 1 0 1 
5044572 32 9 17 6 24 
5044573 2 2 0 0 2 
5104532 1 1 0 0 1 
5104552 1 1 0 0 0 
5104572 1 1 0 0 1 
5111432 1 1 0 0 1 




API All Blood Urine Bile TEM-1 producer 
Code 
5144102 1 0 0 1 0 
5144112 3 2 1 0 0 
5144152 8 1 6 1 6 
5144172 2 1 1 0 1 
5144412 1 1 0 0 0 
5144500 1 0 1 0 1 
5144502 1 0 0 1 0 
5144510 1 1 0 0 0 
5144512 60 31 25 4 39 
5144513 4 4 0 0 3 
5144532 28 8 18 2 22 
5144542 3 3 0 0 1 
5144550 2 0 1 1 1 
5144552 91 43 39 9 47 
5144553 1 1 0 0 0 
5144562 3 2 0 1 1 
5144570 1 1 0 0 0 
5144572 101 33 43 25 60 
5144573 2 1 1 0 2 
6044572 1 0 0 1 1 
7044572 2 0 1 1 2 
7144502 1 1 0 0 0 
7144572 3 1 2 0 2 
no. of 
strains = 523 222 201 100 303 




Table 14. Antibiotic susceptibilities of 340 ampicillin-
resistant (MICs > 16 mg/l) E. coli 
Antimicrobial MIC (mg/l) Cumulative 
agent Range M I C^q M I C ^q % 
resistance 
Ampicillin 32 - 16384 512 4096 100.00 
Amoxycillin 128 - >65536 4096 >65536 100.00 
Amp/Sul* 4 一 >64 16 >64 50.29 
Amo/Cla 4 - —64 8 —32 41.18 
Cloxacillin 8 - >32 >32 >3 2 98.24 
Carbenicillin 4 - >256 >256 >256 97.65 
Piperacillin 2 - >256 一 3 2 >256 59.12 
Cephalothin 0.5 - 64 8 16 87.94 
Cephradine 2 - 6 4 8 64 85.88 
Cephaloridine 1 - 6 4 8 32 76.18 
Cephalexin 2 - 64 8 16 69.12 
Cefoxitin 0.12 - 64 4 8 16.47 
Cefamandole 0.25 - 64 2 16 3.53 
Cefaclor 0.5 - 64 2 8 3.24 
Cefuroxiitie 0.25 - 128 4 8 2.06 
Cefoperazone <0.03 - 64 1 8 1.47 
Ceftazidime <0.03 - 8 0.12 0.25 0.29 
Cefotaxime <0.03 - 4 <0.03 0.12 0.29 
Ceftriaxone <0.03 - 1 <0.03 0.12 0.00 
Moxalactam <0.03 - 16 ~0.12 0.25 0.00 
Aztreonam <0.03 - 8 0.12 0.5 0.00 
Imipenem —0.06 - 0.5 0.12 0.25 0.00 
Chloramphenicol 1 - >256 128 >256 60.29 
Trimethoprim <0.03 - >64 0.5 一64 37.06 
Gentamicin 0.12 - >256 0.5 64 23.24 
Tobramycin 0.12 - —64 0.5 8 17.35 
Amikacin 0.06 - 8 1 2 0.00 , 
* Amp/Sul = Ampicillin/sulbactam 
Amo/Cla = Amoxycillin/clavulanate 
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Table 22. Summary of the preparation of 13-lactamases 
Autotransfer frequencies of ampicillin-resistant 
E• coli 
Strain Transfer Strain Transfer 
frequencies frequencies 
B074 1.0 X 10"*^ U008 3.7 x 10_10 
B075 2.7 X 10二 U065 1.1 x 
B081 1.6 X 10:6 U067 2.5 x 1 0 一 1 0 
B108 3.5 X U079 3.1 X lO"^^ 
B112 4 . 1 X 1 0 一 5 U081 4 . 5 X 1 0 一 
B114 2.0 X U082 7.5 X 
B116 2.6 X U088 1.4 X 10一^ 
B117 2.6 X U089 2.2 X 10"® 
B118 2.1 X U090 1.3 x 10"^ 
B140 1.4 X 10"^ U091 1.3 x 10_10 
B142 5.2 X U092 5.0 X 10"^ 
B152 4.6 X 10:6 U096 2.0 X 10一8 
B153 2.6 X 10_11 U102 1.0 X 1 0一 U 
B154 1 . 2 X 1 0 一 1 1 U103 5 . 0 X 1 0 一 已 
B155 4 . 4 X U105 9 . 1 X 1 0 一 9 
B175 4 . 3 X 1 0 " ^ U110 1 . 1 X 1 0 一 1 1 
B 1 7 9 2 . 6 X 1 0 " ^ U 1 1 2 2 . 6 x 1 0 一 丄 丄 
B187 1 . 6 X 1 0 一 = U115 1 . 2 X 1 0 一 9 
B191 7 . 1 X 1 0 " 2 U117 1 . 4 X 1 0 一 了 
B198 4.4 X 10"® U123 1.3 X 
B205 1.8 X 10"® U132 1.9 X 10_9 
B208 3.1 X 10""° U136 1.5 x 1 0 一 9 
B222 3.6 X 10一〗 U138 8.6 X 10一丄。 
G006 1 .6 X 10一8 U142 1 . 4 X 10一8 
G026 1.5 X U147 6.4 X 10_11 
G029 4 . 4 X 1 0 - 。 U149 2 . 6 X 1 0 一 工 。 
G030 9.0 X 10一10 U150 1.0 X 10"® 
G036 4.4 X 10一=0 U159 2.5 X 10"^ 
G042 5.5 X 10一= U160 1.9 X 10_7 , 
G044 1.1 X 1 0 ” U168 6.6 x l O ^ U 
G046 6 .0 X 1 0 一 。 U169 1 .7 X 10一日 
G048 1.3 X \ U170 4.5 X 
G051 3.7 X 10-10 U182 5.3 X 10"^ 
G058 2.6 X U188 0.5 X 
G059 2.5 X U190 2.8 X 
G072 1.6 X 10一11 U201 4.0 x 10_12 
Total = 72 strains 
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Table 22. Summary of the preparation of 13-lactamases 
Plasmid profiles and location of TEM-1 genes in 42 
ampicillin-resistant E• coli and 
their transconjugants 
Organism Plasmid profile Transferable 
Number (Md) plasmid (Md) 
with TEM-1 gene 
^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^gp ^^ ^^ ^^ WM mam ^m ^m mm mmt mm» mm mm mm mb ^m m 
B006* 66.94, 58.09 
TB006# 66.94, 58.09 58.09 
B033 61.51, 39.93 
TB033 61.51, 39.93 39.93 
B075 76.11 
TB075 76.11 76.11 
B081 65.46, 58.01 
TB081 58.01 58.01 
B112 61.06, 40.94, 0.96 
TB112 40.94 40.94 
B116 91.05, 48.04, 40.94, 1.96 
TB116 91.05, 48.04, 1.96 91.05 
B117 77.60, 61.80, 43.70 
TB117 77.60, 43.70 43.70 
B118 77.60, 56.37, 44.35 
TB118 56.37, 44.35 44.35 
B142 86.10, 54.25, 32.26 
TB142 86.10, 54.25 86.10 
B175 57.26, 2.27, 1.97 
TB175 57.26 57.26 
B179 70.68, 53.38, 3.46, 1.71, 1.49 
TB179 70.68 70.68 
B187 66.18, 58.42 
TB187 58.42 58.42 
B198 76.10 
TB198 76.10 76.10 
G006 83.77, 4.35, 2.60, 1.77, 0.63 、 
TG006 83.77 83.77 
G026 60.58, 25.30, 21.87, 5.10, 3.30, 2.47 
TG026 60.58, 、 5.10, 3.30 60.58, 5.10 
3.30 
G030 56.33, 52.37, 25.30 
TG030 56.33 56.33 
G036 67.30, 4.40, 1.91, 0.39 
TG036 67.30 67.30 
G042 44.77 
TG042 44.77 44.77 
G044 59.62, 56.84, 54.19, 3.24 
TG044 56.84 56.84 




TG046 59.62 59.62 
G051 55.20, 52.52, 5.32 
TG051 55.20 55.20 
G058 52.52, 47.55, 40.95, 26.16, 2.79 
TG058 52.52 52.52 
G068 65.79, 3.11, 2.03, 1.42 
TG068 65.79 65.79 
G072 65.79, 57.08 
TG072 65.79, 57.08 57.08 
U079 80.99 
TU079 80.99 80.99 
U081 73.66, 60.73, 2.77 
TU081 73.66, 60.73, 2.77 60.73 
U089 73.66, 64.77, 4.35 
TU089 73.66 73.66 
U090 90.12 
TU090 90.12 90.12 
U091 90.12, 78.56, 68.09, 59.71, 34.48 
TU091 78.56, 68.09, 59.71, 34.48 68.09 
U092 73.35, 59.71 
TU092 59.71 59.71 
U102 89.69, 12.14 
TU102 89.69 89.69 
U105 70.88, 63.01, 29.33, 4.47 
TU105 63.01, 29.33, 4.47 29.33 
UllO 70.88, 39.36, 2.20 
TUllO 70.88, 39.36 70.88 
U117 82.90, 75.70, 69.90, 63.80 
TU117 67.90, 63.80 67.90, 63 A 
U123 85.60, 72.11, 57.36, 34.29, 2.47, 2.08 
TU123 72.11, 57.36, 34.29 72.11 
U132 52.99, 2.04, 1.75 
TU13 2 52.99 52.99 
U149 60.80, 36.27 
TU149 60.80 60.80 
U168 79.73, 63.01, 2.34 
TU168 63.01 63.OJ. 
U170 89.69, 66.83, 59.41, 44.28 
TU17 0 89.69, 66.83 89.69 
U182 58.33, 46.96, 2.y65 
TU182 58.33, 46.96 58.33 
U188 80.77, 33.91, 1.38 
TU188 33.91 33.91 
U201 95.98 
TU2 01 95.98 95.98 





Distribution of ^-lactamases in ampicillin-resistant 
E. coli in Hong Kong by analytical lEF 
. . . 
> 
\ 

















































































































































































































































































Table 22. Summary of the preparation of 13-lactamases 
Wavelength of peak maximum and extinction 
coefficient of B-lactam substrates 
Antibiotic Wavelength Extinction 
(nm) coefficient 
— 1 — 1 ； i M 上 c m 上 
Amoxycillin 235 0.00725 
Ampicillin 23 5 0.00200 
Carbenicillin 235 0.00264 
Ceftazidime 254 0.02000 
Cephaloridine 254 0.01200 
Cephalothin 254 0.00980 
Cefuroxime 254 6.01650 
Cefamandole 254 0.00890 
Oxacillin 235 0.01300 
Penicillin G 235 0.00158 
Nitrocefin 500 0.02800 
Cephalosporin C 254 0.00700 
\ 
‘ \ \ 
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Table 22. Summary of the p r e p a r a t i o n of 13-lactamases 
ampicillin/sulbactam and 
amoxycillin/clavulanate 
against 303 TEM-1 producing E. coli 
MIC No. of strains jnhibited by 
(mg/1) Ampicillin Amp/sul Amoxycillin Amo/Cla 
<2 一 一 一 一 
_4 - 20 - 17 
8 一 135 一 178 
16 - 59 - 74 
32 - 50 - 34 
64 5 34 -
128 39 5 - -
256 48 一 - -
512 81 - - -
1024 46 - - -
2048 19 - 42 
4096 5 6 - 123 -
>8 1 9 2 9 一 138 -
MICcq 512 8 4096 8 
MICgQ 4096 64 >8192 32 
% Strains 
resistant 100.00 48.84 100.00 35.64 
* Amp/Sul = ampicillin/sulbactam 
Amo/Cla = amoxycillin/clavulanate 
V 
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Table 22. Summary of the preparation of 13-lactamases 
Principal resistance patterns of 303 TEM-1 
producing E• coll 
No. of Resistance pattern No. of 
antibiotics strains 
2 AmpC 26 (8.85%) 
1 Amp 23 (7.60%) 
6 AmpAugPipCrCorC 15 (4.95%) 
5 AmpAugPipCrCor 10 (3.30%) 
7 AmpAugPipCrCorMaC 10 (3.30%) 
2 AmpPip 9 (2.87%) 
93 (30.69%) > 
\ 
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Table 22. Summary of the preparation of 13-lactamases 
B117, TB117 and K12 14R525 (K12) to 
6-lactam antibiotics 
MIC (mg/l) 
Antibiotic U117 TU117 B117 TB117 K12 
Ampicillin 4096 4096 128 128 4 
Sulbactam 64 64 16 32 * 
Ampicillin/sulbactam 
(1:1) 64/64 32/32 4/4 4/4 4/4 
Amoxycillin >819 2 >8192 2048 2048 4 
Amoxycillin/clavulanate 
(2:1) 32/16 32/16 4/2 4/2 4/2 
Carbenicillin >1024 >1024 512 512 8 
Piperacillin 128 128 8 * 8 2 
Cefamandole 8 8 1 0.5 1 
Cefoperazone 4 2 0.12 0.12 0.25 
Cefuroxime 4 4 2 2 4 
Ceftazidime 0.12 0.12 <0.06 <0.06 0.12 
Cefotaxime <0.06 <0.06 <0.06 <0.06 <0.06 
Ceftriaxone <0.06 <0.06 <0.06 <0.06 <0.06 
* Not tested 
• � \ 
< �’ 
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Table 22. Summary of the preparation of 13-lactamases 
Comparison of the substrate profiles (relative 
to ampicillin) from the crude enzyme 
preparations of two ampicillin-resistant 
E. coli and their transconjugants 
Substrate U117 TU117 B117 TB117 
Penicillin G 111.7 102.3 90.9 116.7 
Ampicillin 100.0 100.0 100.0 100.0 
Cephaloridine 37.4 37.8 30.5* 37.6 
Cephalothin 18.9 30.5 22.1 12.3 
Cefamandole 5.7 6.1 6.3 5.4 
Ampicillin/sulbactam* 45.8 58.4 39.6 64.3 
Cephaloridine/Sulbactam 5.3 8.4 8.2 1.5 
* addition of 5>iM Sulbactam 
w 
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Table 22. Summary of the preparation of 13-lactamases 
Strain 
Procedures K12 TB117 TU117 
Starting material (1) 5 5 5 
Wet weight (g) 13.90 13.30 13.70 
Viable cell count (cfu/ml) 
Before F.P. disruption 3.6 4.1 xlO^^ 4.2 
After F.P. disruption 9.6 xlO^ 3.1 xlO^ 6.6 xlO^ 
% efficiency of breakage 99.99 99.99 99.99 
Dry weight (g) 1.8 2.0 1.7 
Reconstituted with DW (ml) 20 20 2 0 
Gel filtration* 
Active fractions # 47-62 45-65 
Total volume (ml) # 84 112 
Flow rate (ml/min) 0.22 0.21 0.18 
Preparative lEF 
Active fractions # 3 - 7 6 - 10 
Total volume (ml) # 8.00 9.20 
pH # 5.07-7.12 5.09-6.59 
Note:-
• \ 
* 5 ml of crude enzyme was loaded in each run 
# Not done (very low enzyme activity) 
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Table 23. 
Summary of the purification of B-lactamases 
from E. coli 
> 
\ 











































































































































































































































































































































































































































































































































































































































































































































































































































































































































Table 24. The substrate profiles of purified 
B-lactamases TU117 and TB117 
Subs七rate Enzyme Km* Sp# Rel@ P.E.a Rel^ 
act Sp act P.E. 
Penicillin G TU117 58 96229 177 1659.1 107.0 
TB117 50 86617 168 1732.3 101.3 
Ampicillin TU117 35 54300 100 1551.4 100.0 
TB117 30 51320 100 1710.7 100.0 
Nitrocefin TU117 50 46544 85 930.9 60.0 
TB117 30 40732 79 1357.7 79.0 
Cephaloridine TU117 140 48268 89 344.8 22.2 
TB117 160 45257 88 282.9 16.5 
> 
Cephalothin TU117 100 13297 23 133.0 8.6 
TB117 70 11055 22 158.0 9.2 
Cefamandole TU117 160 12690 23 79.3 5.1 
TB117 140 12173 24 87,0 5.1 
Cefoperazone TU117 180 10759 20 59.8 3.8 
TB117 170 8370 16 49.2 2.9 
* : Km - Michaelis-Menten constant (>iM) 
# : Sp. act. - Specific activity 
(;jinol of substrate/min/mg protein) 
@ : Rel. Sp. act. 一 Relative specific activity 
a : P.E. - Physiological efficiency 
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Name 
Name Acyl residue R 
Amoxicll.n Ampic.llin 
((o-a-Amino-p-hydroxybenzyl)- i ({o-a-Aminot3en2yl)-penic:llin) NH2 
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Figure 7. 
Chemical structure of different classes 
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l a l 乂 C H 3 S ^ C H 3 
I I "tH3 ——^ I 」'々CH3 
O ^ . ' c o o - 〇 〇 一 c o o 
+ (3-lactamase 
p e n i c i l l i n D - a - p e n i c i l l o a t e 
Ibl \ / S 
c e p h a l o s p o r i n 
COO" 
/ +- 3-lactar.ase \ 
\ 
H \ 
C O O ceo' 
u n s t a b l e c e p h a l o s p o r a t e unstable c e p h a l o s p o r a t e 
(when R‘ is n o t a l e a v i n g group) (when R ‘ is a l e a v i n g group) 
\ . / 
f r a g m e n t a t i o n p r o d u c t s 
Figure 10. 
Flow diagram of procedures utilized for 
the transfer of DNA onto membrane 
(Southern blotting) 
Plasmid agarose gel electrophoresis 
0.25 M HCl 
for 20 min. 
V 
Depurinate DNA 
1.5 M NaCl 
0.5 M NaOH 
for 30 min. 
V 
Hydrolyze & denature DNA 
1.5 M NaCl, 
1 M Tris, pH 7.5 




for 6 h 
\ 
V 
Transfer to membrane 
UV illumination 
for 5 min. 
V 
Fix DNA onto membrane 
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Figure 14. 
Flow diagram of procedures utilized 
for DNA hybridization 
Membrane 
6x SSC 
5x Denhardt's solution 
0.05% sodium pyrophosphate 
100 ；Lig/ml denatured salmon sperm DNA 
0.5% SDS 




Ix Denhardt^s solution 
0.05% sodium pyrophosphate 
100 ；ag/itil denatured salmon sperm DNA 
0.5 ng/ml labeled probe 




0.05% sodium pyrophosphate 
5 min. at room temp. 
V 
Washing (3 times) 
6x SSC, 
0.05% sodium pyrophosphate 
30 min. at 39°C for TEM-1 ‘ 
37°C for TEM-2 
、 45^C for OXA-1 
V 
Final washing 
Expose to X-ray film at -70°C 




Figure 12. Flow diagram of procedures utilized for 
preparation of crude E. coli enzyme 
(Identification of B-lactamases by 
analytical lEF) 
Stock culture 
Streak bacteria onto IST agar 
containing 16 mg/l Amp 
Incubate for 24 h 
V 
Pure colonies 
Pick several colonies & inoculate 
into 10ml BHI broth 
V 
Broth culture 
Shake at 100 rpm & incubate for 4 h 
Centrifuge at 2,000 g for 30 min. 
V 
Pellet 





Resuspend in DW 、 
Ultrasonic disintegration 





Crude enzyme (stored at -20°C) 
s' 
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Figure 13. Flow diagram of procedures utilized for 
preparation of E. coll enzymes 
(Purification of 6-lactamases) 
Stock culture 
Streak bacteria onto IST agar 
containing 16 mg/l Amp 
Incubate 24 h 
V 
Pure colonies 
Pick several colonies & inoculate 
into 100 ml IST broth 
Shake at 100 rpm & incubate 
V for 18 h 
Seed broth culture 
Inoculate into 5 1. IST broth 
(1:100 dilution) 
Shake at 150 rpm & incubate for 4 h 
V 
Broth culture 
Centrifuge x 2,000 g for 30 min. 
at 4 
Wash 2x 0.1 M PB pH 7.0 at 4°C 
Centrifuge x2,000 g for 30 min. 
V at 4 °C 
Pellet 
Weigh 、 
Resuspend in 0.1 g/lml 
、 Tris-EDTA-sucrose 
buffer pH 7.0 
V 
Bacterial suspension 
Perform viable cell count 
Disrupt by French Pressure Cell 






Perforin viable cell count 




Measure protein concentration & 
13-lactamase activities 
Precipitate with 0.4 % Protamine 
sulphate for 1 h at 4。。 




Dialyse 3x in 5 1. 25 mM Tris 
pH 7.0 for 72 h at 






Reconstitute to 20 ml with DW 
V 






Flow diagram of procedures utilized for 
purification of E. coli B-lactamases 
Crude enzyme 
Gel filtration chromatography by 
Sephadex G-lOO in 15 mM 
Triethanolamine-HCl buffer 
pH 7.25 at 4°C 
Measure protein concentration & 
13-lactamase activities 
Combine active fractions 
V 
Active fractions 
Preparative lEF using 
Rotofor in pH gradient 
3.5-9.5 at 4°C 
Measure protein concentration & 
B-lactamase activities 
Combine active fractions 
V 
Active fractions 
Chromatography in Sephadex G-lOO 
at 4°C 
Measure protein concentration & 
B-lactamase activities 
Combine active fractions 
V 
- lactamase 、 
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Figure 15.1 
Distribution of the 340 ampicillin-resistant E• coli 
against an extended range concentration of 
























































































































































































































































































































































































































































































Distribution of the 340 ampicillin-resistant E• coll 
against an extended range concentration of 


















































































































































































































































































































































































































Comparative antimicrobial activities of 
ceftazidime, cefoperazone, cefuroxime, 
Unasyn (Ampicillin/sulbactam) and 
piperacillin against 











































































































































































Comparative antimicrobial activities of 
amikacin, tobramycin, gentamicin 
trimethoprim and chloramphenicol against 
























































































































































Agarose gel electrophoresis of plasmid DNA 
stained with ethidium bromide 
Lane 
1 E. coli 14R525 
2 Molecular size markers (119.4, 61.5, 48.8) * 
3 Molecular size markers (98.5, 58.2, 31.1) 
4 Molecular size markers (91.4, 40) 
5 E. coli U117 
6 E. coli TU117 
7 E. coli Bill 
8 E. coli TB117 





















Colony blot hybridization of J3-lactamase producing 
E. coli with TEM-1 oligonucleotide probe 
Al B117 B1 TB117> 
(TEM-1 producer) (TEM-1 producer) 
A2 U117 B2 TU117 
(TEM-1 producer) (TEM-1 producer) 
A3 Standard B3 E. coll K12 
TEM-1 producer 14R525 
A4 U112 B4 Standard 
(TEM-1 producer) TEM-2 producer 
A5 E.coli B5 U182 
ATCC 25922 (TEM-1 producer) 
“ \ \ 
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Southern blot hybridization of plasmid DNA 
with TEM-1 oligonucleotide probe 
Lane 
> * 
1 E• coli TU117 (Transconjugant) 
2 E• coll U117 (ampicillin/sulbactam-
resistant) 
3 E. coli TB117 (Transconjugant) 
4 E• coli B117 (ampicillin/sulbactam-
sensitive) 
… \ \ 
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Figure 21. 
Relationship between ampicillin MIC and 
Unasyn (ampicillin/sulbactam) MIC 
> > 
MIC = mg/l 
Unasyn MIC 
= 0 . 5 8 X ampicillin MIC + 1.258 (r= 0.86) 
Correlation coefficient = 0.86 
、• \\ 
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Figure 22. 
Absorption spectrum of nitrocefin before and 
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Figure 23. 
Relationship between ampicillin MIC and 
log^Q B-lactamase activities 
> > 
Unit of 5-lactamase activity 
=>imol nitrocefin/min/mg protein 
log^Q B-lactamase activity 
= 0 . 2 1 X ampicillin MIC + 2.3274 (r= 0.75) 
Correlation coefficient = 0.75 
“ \ \ 
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F i g u r e 24. 
Separation of 13-lactamase (E. coll K12 14R525) 
from the S e p h a d e x G - l O O column in 
15 mM T r i e t h a n o l a m i n e - H C l buffer pH 7.25 
B - l a c t a m a s e activity m e a s u r e d 
~ C •二 • u s i n g ampicillin as s u b s t r a t e 
— P r o t e i n concentration 
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F i g u r e 25. 
Separation of B — l a c t a m a s e (Z. coll TB117) 
from the S e p h a d e x G - 1 0 0 column in 
15 mM T r i e t h a n o l a m i n e - H C l buffer pH 7.25 
> 
> 
B - l a c t a m a s e activity m e a s u r e d 
: G H u s i n g ampicillin as s u b s t r a t e 
— • •一 P r o t e i n concentration 
• -
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F i g u r e 26. 
Separation of B - l a c t a m a s e {E. coli TU117) 
from the S e p h a d e x G - l O O column in 
15 mM T r i e t h a n o l a m i n e - K C l buffer pH 7.25 
> * 
B - l a c t a m a s e activity m e a s u r e d 
— 一 — u s i n g ampicillin as s u b s t r a t e 
<M« 
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F i g u r e 27. 
Separation of i3-lactamase {E. coli TB117) 
bv p r e p a r a t i v e i s o e l e c t r i c focusing 
in p H g r a d i e n t 3.5-9.5 
t 
5-lactaiiiase activity n e a s u r e d 
_ C z 3 u s i n g a m p i c i l l i n as subst::rrat:e 
人 • 一 P r o t e i n concentration 
z � 181 
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F i g u r e 28. 
Separation of B - l a c t a m a s e (E. coli TU117) 
by p r e p a r a t i v e i s o e l e c t r i c focusing 
in p H g r a d i e n t 3.5-9.5 
• 一 
13-lactamase activity m e a s u r e d 
— — 一 using, a m p i c i l l i n as s u b s t r a t e 
'— !_) —i 
一 •一 一 • — — • P r o t e i n concentration 
\ \ 
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The specific B - l a c t a m a s e activities in 
different enzyme purification stages 
Sp. a c t . = >imol of ampicillin/uiin/mg protein 
Purification stage: 
la French p r e s s u r e disruption 
lb P r o t a m i n e sulphate treatment 
Ic C e n t r i f u g a t i o n and dialysis 
Id F r e e z e - d r y i n g and reconstitution in DW 
2 G e l filtration (Sephadex G-lOO) 
3 Preparative isoelectric focusing 
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Figure 30. 
The total B-lactamase a c t i v i t i e s in different 
enzyme p u r i f i c a t i o n stages 
> 
Total activity= ；amol of ampicillin/min 
Purification stage: 
la French p r e s s u r e disruption 
lb P r o t a m i n e s u l p h a t e treatment 
Ic C e n t r i f u g a t i o n and dialysis 
Id F r e e z e - d r y i n g and reconstitution in DW 
2 Gel f i l t r a t i o n (Sephadex G-100) 
























































































































Analytical isoelectric focusing of 6-lactainases 
on polyacrylamide g e l , nitrocefin staining 
Lane t 
1 TU117 (fraction 2, after gel filtration) 
2 TU117 (fraction 3, 
after preparative lEF) 
3 TB117 (fraction 2 , after gel filtration) 
4 TB117 (fraction 3, 
a f t e r preparative lEF) 
5 pi markers 
6 Standard T E M - 1 B-lactamase 
7 TU117 (fraction 3) + TB117 (fraction 3) 
、- \、 
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Figure 32. 
Analytical isoelectric focusing of B-lactamases on 
polyacrylamide g e l , silver staining 
. - • • • -
> > 
Lane 
1 pi markers 
2 TU117 (fraction 3, 
after p r e p a r a t i v e 工EF) 
3 TU117 (fraction 2 , after gel filtration) 
4 TB117 (fraction 3, 
after p r e p a r a t i v e lEF) 
5 TB117 (fraction 2 , after gel filtration) 
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Figure 33. 
SDS-polyacrylamide g e l e l e c t r o p h o r e s i s of 
purified B - l a c t a m a s e s , silver staining 
L a n e , 
1 TU117 (fraction 3) + TB117 (fraction 3) 
2 TU117 (fraction 3, 
a f t e r p r e p a r a t i v e I£F) 
3 TB117 (fraction 3, 
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